Interactions	O
between	O
the	O
class	B-protein
II	I-protein
transactivator	I-protein
and	O
CREB	B-protein
binding	I-protein
protein	I-protein
increase	O
transcription	O
of	O
major	B-DNA
histocompatibility	I-DNA
complex	I-DNA
class	I-DNA
II	I-DNA
genes	I-DNA
.	O

Class	B-DNA
II	I-DNA
major	I-DNA
histocompatibility	I-DNA
(	I-DNA
class	I-DNA
II	I-DNA
)	I-DNA
genes	I-DNA
are	O
regulated	O
in	O
a	O
B-cell-specific	O
and	O
gamma	O
interferon-inducible	O
fashion	O
.	O

The	O
master	O
switch	O
for	O
the	O
expression	O
of	O
these	O
genes	O
is	O
the	O
class	B-protein
II	I-protein
transactivator	I-protein
(	O
CIITA	B-protein
)	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
one	O
of	O
the	O
functions	O
of	O
CIITA	B-protein
is	O
to	O
recruit	O
the	O
CREB	B-protein
binding	I-protein
protein	I-protein
(	O
CBP	B-protein
)	O
to	O
class	B-DNA
II	I-DNA
promoters	I-DNA
.	O

Not	O
only	O
functional	O
but	O
also	O
specific	O
binding	O
interactions	O
between	O
CIITA	B-protein
and	O
CBP	B-protein
were	O
demonstrated	O
.	O

Moreover	O
,	O
a	O
dominant	O
negative	O
form	O
of	O
CBP	B-protein
decreased	O
the	O
activity	O
of	O
class	B-DNA
II	I-DNA
promoters	I-DNA
and	O
levels	O
of	O
class	B-protein
II	I-protein
determinants	I-protein
on	O
the	O
surface	O
of	O
cells	O
.	O

Finally	O
,	O
the	O
inhibition	O
of	O
class	B-DNA
II	I-DNA
gene	I-DNA
expression	O
by	O
the	O
glucocorticoid	O
hormone	O
could	O
be	O
attributed	O
to	O
the	O
squelching	O
of	O
CBP	B-protein
by	O
the	O
glucocorticoid	B-protein
receptor	I-protein
.	O

We	O
conclude	O
that	O
CBP	B-protein
,	O
a	O
histone	B-protein
acetyltransferase	I-protein
,	O
plays	O
an	O
important	O
role	O
in	O
the	O
transcription	O
of	O
class	B-DNA
II	I-DNA
genes	I-DNA
.	O

MoLECcULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Jan.	NULL
1999	NULL
,	NULL
p.	NULL
941-947	NULL
0270-7306/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

1	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Interactions	NULL
between	NULL
the	NULL
Class	NULL
II	NULL
Transactivator	NULL
and	NULL
CREB	NULL
Binding	NULL
Protein	NULL
Increase	NULL
Transcription	NULL
of	NULL
Major	NULL
Histocompatibility	NULL
Complex	NULL
Class	NULL
II	NULL
Genes	NULL
JOSEPH	NULL
D.	NULL
FONTES	NULL
,	NULL
SATOSHI	NULL
KANAZAWA	NULL
,	NULL
DICKSON	NULL
JEAN	NULL
,	NULL
anp	NULL
B.	NULL
MATIJA	NULL
PETERLIN®	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Departments	NULL
of	NULL
Medicine	NULL
,	NULL
Immunology	NULL
,	NULL
and	NULL
Microbiology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
San	NULL
Francisco	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94143-0703	NULL
.	NULL

Received	NULL
10	NULL
June	NULL
1998/Returned	NULL
for	NULL
modification	NULL
13	NULL
August	NULL
1998/Accepted	NULL
14	NULL
October	NULL
1998	NULL
Class	NULL
II	NULL
major	NULL
histocompatibility	NULL
(	NULL
class	NULL
II	NULL
)	NULL
genes	NULL
are	NULL
regulated	NULL
in	NULL
a	NULL
B-cell-specific	NULL
and	NULL
gamma	NULL
interferon-inducible	NULL
fashion	NULL
.	NULL

The	NULL
master	NULL
switch	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
is	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CHITA	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
one	NULL
of	NULL
the	NULL
functions	NULL
of	NULL
CIITA	NULL
is	NULL
to	NULL
recruit	NULL
the	NULL
CREB	NULL
binding	NULL
protein	NULL
(	NULL
CBP	NULL
)	NULL
to	NULL
class	NULL
II	NULL
promoters	NULL
.	NULL

Not	NULL
only	NULL
functional	NULL
but	NULL
also	NULL
specific	NULL
binding	NULL
interactions	NULL
between	NULL
CIITA	NULL
and	NULL
CBP	NULL
were	NULL
demonstrated	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
CBP	NULL
decreased	NULL
the	NULL
activity	NULL
of	NULL
class	NULL
II	NULL
promoters	NULL
and	NULL
levels	NULL
of	NULL
class	NULL
II	NULL
determinants	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
glucocorticoid	NULL
hormone	NULL
could	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
squelching	NULL
of	NULL
CBP	NULL
by	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
CBP	NULL
,	NULL
a	NULL
histone	NULL
acetyltransferase	NULL
,	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
major	NULL
histocompatibility	NULL
(	NULL
MHC	NULL
)	NULL
complex	NULL
class	NULL
II	NULL
(	NULL
class	NULL
II	NULL
)	NULL
genes	NULL
is	NULL
controlled	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcrip-tion	NULL
.	NULL

Their	NULL
coordinate	NULL
B-cell-specific	NULL
and	NULL
gamma	NULL
interferon-inducible	NULL
expression	NULL
is	NULL
dictated	NULL
by	NULL
shared	NULL
cis-acting	NULL
elements	NULL
in	NULL
their	NULL
promoters	NULL
.	NULL

At	NULL
least	NULL
four	NULL
conserved	NULL
sequences	NULL
,	NULL
called	NULL
the	NULL
S	NULL
,	NULL
X	NULL
,	NULL
X2	NULL
,	NULL
and	NULL
Y	NULL
boxes	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
2	NULL
and	NULL
33	NULL
)	NULL
.	NULL

With	NULL
the	NULL
help	NULL
of	NULL
the	NULL
heterotrimeric	NULL
nuclear	NULL
factor	NULL
Y	NULL
complex	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
Y	NULL
box	NULL
(	NULL
29	NULL
,	NULL
42	NULL
,	NULL
52	NULL
)	NULL
,	NULL
the	NULL
multimeric	NULL
regulatory	NULL
factor	NULL
X	NULL
(	NULL
RFX	NULL
)	NULL
complex	NULL
binds	NULL
specifically	NULL
to	NULL
S	NULL
and	NULL
X	NULL
boxes	NULL
(	NULL
15	NULL
,	NULL
21	NULL
)	NULL
.	NULL

The	NULL
X2	NULL
binding	NULL
protein	NULL
also	NULL
facilitates	NULL
the	NULL
binding	NULL
of	NULL
RFX	NULL
to	NULL
these	NULL
conserved	NULL
upstream	NULL
sequences	NULL
(	NULL
CUS	NULL
)	NULL
(	NULL
30	NULL
,	NULL
34	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
occupancy	NULL
of	NULL
these	NULL
CUS	NULL
is	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
25	NULL
)	NULL
;	NULL
expression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CHTA	NULL
)	NULL
is	NULL
also	NULL
required	NULL
(	NULL
48-50	NULL
)	NULL
.	NULL

CHTA	NULL
is	NULL
a	NULL
125-kDa	NULL
transcriptional	NULL
coactivator	NULL
which	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
DNA	NULL
directly	NULL
(	NULL
49	NULL
)	NULL
but	NULL
interacts	NULL
with	NULL
protein	NULL
complexes	NULL
on	NULL
CUS	NULL
.	NULL

Its	NULL
C-terminal	NULL
800	NULL
amino	NULL
acids	NULL
interact	NULL
with	NULL
these	NULL
DNA-bound	NULL
proteins	NULL
(	NULL
43	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
weak	NULL
interactions	NULL
between	NULL
CIITA	NULL
and	NULL
RFX5	NULL
,	NULL
which	NULL
is	NULL
the	NULL
largest	NULL
subunit	NULL
of	NULL
RFX	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
N	NULL
terminus	NULL
of	NULL
CHTA	NULL
contains	NULL
a	NULL
transcriptional	NULL
activation	NULL
domain	NULL
of	NULL
143	NULL
amino	NULL
ac-ids	NULL
,	NULL
which	NULL
is	NULL
rich	NULL
in	NULL
acidic	NULL
amino	NULL
acids	NULL
(	NULL
43	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Mutational	NULL
analyses	NULL
of	NULL
this	NULL
region	NULL
identified	NULL
two	NULL
putative	NULL
«	NULL
helices	NULL
which	NULL
are	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
CIITA	NULL
(	NULL
18	NULL
)	NULL
.	NULL

They	NULL
bind	NULL
to	NULL
the	NULL
32-kDa	NULL
subunit	NULL
of	NULL
TFIID	NULL
,	NULL
TAF	NULL
,	NULL
,32	NULL
,	NULL
and	NULL
presumably	NULL
activate	NULL
transcription	NULL
by	NULL
recruiting	NULL
TFIID	NULL
to	NULL
the	NULL
promoter	NULL
(	NULL
18	NULL
)	NULL
.	NULL

CHTA	NULL
also	NULL
recruits	NULL
the	NULL
B-cell-specific	NULL
coactivator	NULL
Bob-1	NULL
(	NULL
also	NULL
known	NULL
as	NULL
OBF-1	NULL
or	NULL
OCA-B	NULL
)	NULL
,	NULL
thereby	NULL
increasing	NULL
the	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
CREB	NULL
binding	NULL
protein	NULL
(	NULL
CBP	NULL
)	NULL
,	NULL
which	NULL
interacts	NULL
directly	NULL
with	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
CREB	NULL
,	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
coactivator	NULL
for	NULL
the	NULL
transcription	NULL
of	NULL
cyclic	NULL
AMP-responsive	NULL
genes	NULL
(	NULL
13	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
many	NULL
other	NULL
transcription	NULL
factors	NULL
were	NULL
found	NULL
to	NULL
interact	NULL
with	NULL
CBP	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
19	NULL
)	NULL
.	NULL

*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Departments	NULL
of	NULL
Medicine	NULL
,	NULL
Immunology	NULL
,	NULL
and	NULL
Microbiology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
San	NULL
Francisco	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94143-0703	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
415	NULL
)	NULL
502-1902	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
415	NULL
)	NULL
502-1901	NULL
.	NULL

E-mail	NULL
:	NULL
matija	NULL
@	NULL
itsa.ucsf	NULL
.edu	NULL
.	NULL

941	NULL
Direct	NULL
binding	NULL
of	NULL
CBP	NULL
to	NULL
these	NULL
transcription	NULL
factors	NULL
was	NULL
also	NULL
demonstrated	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
22	NULL
)	NULL
.	NULL

CBP	NULL
activates	NULL
transcription	NULL
through	NULL
its	NULL
histone	NULL
acetyltransferase	NULL
(	NULL
HAT	NULL
)	NULL
activity	NULL
(	NULL
7	NULL
,	NULL
38	NULL
)	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
recruit	NULL
additional	NULL
proteins	NULL
p/CAF	NULL
(	NULL
53	NULL
)	NULL
and	NULL
ACTR	NULL
(	NULL
11	NULL
)	NULL
,	NULL
which	NULL
also	NULL
possess	NULL
HAT	NULL
activities	NULL
.	NULL

Additionally	NULL
,	NULL
CBP	NULL
can	NULL
acetylate	NULL
general	NULL
transcription	NULL
factors	NULL
(	NULL
20	NULL
)	NULL
,	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
its	NULL
transcriptional	NULL
effects	NULL
.	NULL

Finally	NULL
,	NULL
CBP	NULL
binds	NULL
to	NULL
RNA	NULL
helicase	NULL
A	NULL
and	NULL
thereby	NULL
RNA	NULL
polymerase	NULL
II	NULL
holoenzyme	NULL
(	NULL
26	NULL
,	NULL
36	NULL
)	NULL
as	NULL
well	NULL
as	NULL
other	NULL
general	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
include	NULL
TATA-binding	NULL
protein	NULL
(	NULL
3	NULL
,	NULL
14	NULL
)	NULL
and	NULL
TFIIB	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
CBP	NULL
activates	NULL
transcription	NULL
by	NULL
more	NULL
than	NULL
one	NULL
mechanism	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
identified	NULL
CBP	NULL
as	NULL
a	NULL
cofactor	NULL
for	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

We	NULL
found	NULL
that	NULL
CIITA	NULL
and	NULL
CBP	NULL
cooperate	NULL
synergistically	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
DRA	NULL
promoter	NULL
.	NULL

These	NULL
two	NULL
proteins	NULL
also	NULL
bound	NULL
to	NULL
each	NULL
other	NULL
directly	NULL
,	NULL
and	NULL
these	NULL
interactions	NULL
were	NULL
highly	NULL
specific	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
CBP	NULL
,	NULL
(	NULL
DN-CBP	NULL
)	NULL
blocked	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
by	NULL
CBP	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
class	NULL
II	NULL
transcription	NULL
by	NULL
dexamethasone	NULL
,	NULL
which	NULL
is	NULL
a	NULL
glucocorticoid	NULL
hormone	NULL
,	NULL
was	NULL
reversed	NULL
by	NULL
the	NULL
overexpression	NULL
of	NULL
CBP	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
could	NULL
have	NULL
resulted	NULL
from	NULL
the	NULL
squelching	NULL
of	NULL
CBP	NULL
by	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
GR	NULL
)	NULL
.	NULL

From	NULL
this	NULL
and	NULL
previous	NULL
studies	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
CIHITA	NULL
organizes	NULL
multiple	NULL
transcriptional	NULL
activities	NULL
,	NULL
integrating	NULL
inputs	NULL
from	NULL
sequence-specific	NULL
DNA-bound	NULL
proteins	NULL
with	NULL
various	NULL
effector	NULL
pathways	NULL
to	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
transfection	NULL
.	NULL

The	NULL
human	NULL
kidney	NULL
fibroblast	NULL
cell	NULL
line	NULL
293T	NULL
and	NULL
African	NULL
green	NULL
monkey	NULL
kidney	NULL
cell	NULL
line	NULL
COS	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
streptomycin-penicillin	NULL
.	NULL

The	NULL
human	NULL
B-lymphoblastoid	NULL
cell	NULL
line	NULL
RM3	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
streptomycin-penicillin	NULL
.	NULL

All	NULL
cells	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Transfection	NULL
of	NULL
293T	NULL
and	NULL
COS	NULL
cells	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
1	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
(	NULL
including	NULL
10	NULL
ng	NULL
of	NULL
a	NULL
plasmid	NULL
expressing	NULL
hCG	NULL
as	NULL
a	NULL
transfection	NULL
control	NULL
)	NULL
and	NULL
Lipofectamine	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

RM3	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
(	NULL
300	NULL
V	NULL
,	NULL
975	NULL
pF	NULL
)	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
including	NULL
1	NULL
g	NULL
of	NULL
pEGFP	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Plasmid	NULL
DNA	NULL
construction	NULL
.	NULL

pSVCIITA	NULL
,	NULL
pSGCIITA	NULL
,	NULL
and	NULL
pDRASCAT	NULL
(	NULL
17	NULL
)	NULL
and	NULL
pCMVCBP	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
)	NULL
(	NULL
24	NULL
)	NULL
were	NULL
previously	NULL
described	NULL
.	NULL

Plasmids	NULL
expressing	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-CBP	NULL
fusion	NULL
proteins	NULL
were	NULL
constructed	NULL
as	NULL
follows	NULL
.	NULL

The	NULL
appropriate	NULL
region	NULL
of	NULL
CBP	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
942	NULL
FONTES	NULL
ET	NULL
AL	NULL
.	NULL

using	NULL
primers	NULL
containing	NULL
BamHI	NULL
(	NULL
5	NULL
'	NULL
end	NULL
)	NULL
and	NULL
XhoI	NULL
(	NULL
3	NULL
'	NULL
end	NULL
)	NULL
sites	NULL
.	NULL

These	NULL
amplified	NULL
DNAs	NULL
were	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
XhoI	NULL
and	NULL
subcloned	NULL
into	NULL
plasmid	NULL
pGEX4T3	NULL
(	NULL
Promega	NULL
Inc.	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
cut	NULL
with	NULL
the	NULL
same	NULL
enzymes	NULL
.	NULL

Each	NULL
CBP	NULL
insert	NULL
was	NULL
sequenced	NULL
to	NULL
verify	NULL
identity	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
PCR	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
GST-CBP	NULL
(	NULL
1-101	NULL
)	NULL
,	NULL
5-CGCGGATCCATGGCTGAGAACTTGC	NULL
and	NULL
5'-GCAC	NULL
TCGAGCTAGCCACCCAGGCCCTG	NULL
;	NULL
GST-CBP	NULL
(	NULL
461-661	NULL
)	NULL
,	NULL
5	NULL
``	NULL
-CGCGGATCC	NULL
GGCACAGGGCAACAG	NULL
and	NULL
5'-GCACCGGAGCTATATCTTGTAGATTIT	NULL
TCTC	NULL
;	NULL
GST-CBP	NULL
(	NULL
1621-1891	NULL
)	NULL
,	NULL
5'-	NULL
CGCGGATCCTGTATGCCACCATGG	NULL
and	NULL
5-GCACTGGAGCTAGCCTCCCATCGCCTGC	NULL
;	NULL
and	NULL
GST-CBP	NULL
(	NULL
2058-2163	NULL
)	NULL
,	NULL
5-CGCGGATCCCCACCCAGGAGGATCTCACC	NULL
and	NULL
5	NULL
``	NULL
-GCACTCGAGCT	NULL
ATGTCTTGCGATTATAG	NULL
.	NULL

(	NULL
Numbers	NULL
in	NULL
parentheses	NULL
denote	NULL
amino	NULL
acids	NULL
positions	NULL
spanned	NULL
by	NULL
the	NULL
CBP	NULL
constructs	NULL
.	NULL
)	NULL

Plasmid	NULL
pCRDN-CBP	NULL
was	NULL
constructed	NULL
by	NULL
amplifying	NULL
CBP	NULL
cDNA	NULL
sequences	NULL
from	NULL
nucleotides	NULL
5709	NULL
to	NULL
7323	NULL
,	NULL
adding	NULL
an	NULL
ATG	NULL
start	NULL
codon	NULL
and	NULL
consensus	NULL
sequence	NULL
immediately	NULL
preceding	NULL
amino	NULL
acid	NULL
1903	NULL
of	NULL
CBP	NULL
,	NULL
and	NULL
subcloning	NULL
the	NULL
amplified	NULL
product	NULL
directly	NULL
into	NULL
plasmid	NULL
pCR3.1	NULL
(	NULL
InVitrogen	NULL
,	NULL
Carlsbad	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
CBP	NULL
was	NULL
sequenced	NULL
to	NULL
verify	NULL
its	NULL
identity	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
PCR	NULL
were	NULL
5	NULL
%	NULL
-GCCGCCACCATGCCGCAGCCCCCTGCCCaAG	NULL
and	NULL
5'-CTACAAGCCCTCCACAAACTTC	NULL
.	NULL

Reverse	NULL
transcriptase-mediated	NULL
PCR	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
transfected	NULL
293T	NULL
cells	NULL
by	NULL
the	NULL
guanidinium	NULL
acid-phenol	NULL
chloroform	NULL
method	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Reverse	NULL
transcription	NULL
was	NULL
performed	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
total	NULL
RNA	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
(	NULL
Bochringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
Ind	NULL
.	NULL
)	NULL

,	NULL
and	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

One	NULL
microliter	NULL
of	NULL
the	NULL
reverse	NULL
transcriptase	NULL
reaction	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
in	NULL
a	NULL
PCR	NULL
with	NULL
1	NULL
U	NULL
of	NULL
Teg	NULL
polymerase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
in	NULL
a	NULL
50-pl	NULL
reaction	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
reaction	NULL
conditions	NULL
were	NULL
94°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
55°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
72°C	NULL
for	NULL
30	NULL
s	NULL
for	NULL
25	NULL
cycles	NULL
.	NULL

Then	NULL
10	NULL
ul	NULL
of	NULL
each	NULL
reaction	NULL
product	NULL
was	NULL
run	NULL
on	NULL
a	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
CIITA	NULL
were	NULL
previously	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
primers	NULL
for	NULL
human	NULL
TAP1	NULL
were	NULL
5'-AGGTAGACGAGGCTGGGAGCC	NULL
and	NULL
5	NULL
``	NULL
-CATTCTGGAGCATCTGCA	NULL
GG	NULL
.	NULL

CAT	NULL
assay	NULL
and	NULL
FACS	NULL
analysis	NULL
.	NULL

The	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assay	NULL
was	NULL
performed	NULL
exactly	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Forty-eight	NULL
hours	NULL
after	NULL
the	NULL
transfection	NULL
,	NULL
RM3	NULL
cells	NULL
were	NULL
stained	NULL
for	NULL
human	NULL
class	NULL
II	NULL
and	NULL
class	NULL
I	NULL
determinants	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
raised	NULL
against	NULL
HLA-DP	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
Calif	NULL
)	NULL
and	NULL
HLA-A	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-C	NULL
(	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
determinants	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
phyco-erythrin-conjugated	NULL
rat	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
Zymed	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Flu-orescence-activated	NULL
cell	NULL
sorting	NULL
(	NULL
FACS	NULL
)	NULL
analyses	NULL
were	NULL
performed	NULL
on	NULL
a	NULL
FACS-calibur	NULL
apparatus	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Western	NULL
blotting	NULL
.	NULL

Forty-cight	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
COS	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
lysed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
Nonidet	NULL
P40	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
protease	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
cleared	NULL
at	NULL
12,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
supernatants	NULL
were	NULL
incubated	NULL
with	NULL
10	NULL
al	NULL
of	NULL
anti-CBP	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
mixed	NULL
with	NULL
15	NULL
pl	NULL
of	NULL
protein	NULL
A-conjugated	NULL
agarose	NULL
beads	NULL
for	NULL
another	NULL
hour	NULL
,	NULL
and	NULL
immunoprecipitates	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
and	NULL
resuspended	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
.	NULL

Protein	NULL
samples	NULL
were	NULL
then	NULL
resolved	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electro-phoresis	NULL
(	NULL
PAGE	NULL
)	NULL
on	NULL
an	NULL
8	NULL
%	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
using	NULL
a	NULL
Bio-Rad	NULL
(	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
Western	NULL
blotting	NULL
apparatus	NULL
.	NULL

One-quarter	NULL
of	NULL
the	NULL
lysate	NULL
used	NULL
for	NULL
the	NULL
immunoprecipitation	NULL
was	NULL
also	NULL
examine	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
CBP	NULL
and	NULL
CIITA	NULL
in	NULL
transfected	NULL
cells	NULL
.	NULL

Membranes	NULL
were	NULL
blocked	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
overnight	NULL
and	NULL
incubated	NULL
with	NULL
primary	NULL
antibodies	NULL
(	NULL
anti-hemagglutinin	NULL
epitope	NULL
[	NULL
12CA5	NULL
]	NULL
and	NULL
anti-CBP	NULL
)	NULL
for	NULL
at	NULL
least	NULL
1	NULL
h.	NULL
After	NULL
three	NULL
washes	NULL
with	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
,	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
secondary	NULL
antibody	NULL
conjugated	NULL
with	NULL
horseradish	NULL
peroxidase	NULL
for	NULL
1	NULL
h	NULL
,	NULL
washed	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
assay	NULL
(	NULL
ECL	NULL
kit	NULL
;	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
II	NULL
.	NULL
)	NULL

.	NULL

GST	NULL
pull-down	NULL
assays	NULL
.	NULL

GST-CBP	NULL
fusion	NULL
proteins	NULL
were	NULL
produced	NULL
and	NULL
purified	NULL
,	NULL
and	NULL
GST	NULL
pull-down	NULL
assays	NULL
between	NULL
GST-CBP	NULL
and	NULL
in	NULL
vitro-transcribed	NULL
and	NULL
-translated	NULL
CIITA	NULL
and	NULL
CIITA	NULL
deletions	NULL
were	NULL
performed	NULL
exactly	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
18	NULL
)	NULL
.	NULL

RESULTS	NULL
CBP	NULL
and	NULL
CIITA	NULL
increase	NULL
expression	NULL
from	NULL
the	NULL
DRA	NULL
promoter	NULL
synergistically	NULL
.	NULL

Previous	NULL
studies	NULL
demonstrated	NULL
that	NULL
CBP	NULL
facilitates	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
genes	NULL
via	NULL
its	NULL
HAT	NULL
domain	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
22	NULL
)	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
general	NULL
transcription	NULL
factors	NULL
(	NULL
3	NULL
,	NULL
14	NULL
,	NULL
26	NULL
,	NULL
27	NULL
,	NULL
36	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
CBP	NULL
could	NULL
also	NULL
activate	NULL
class	NULL
II	NULL
genes	NULL
and	NULL
if	NULL
it	NULL
cooperated	NULL
with	NULL
CIITA	NULL
,	NULL
transient	NULL
expression	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
human	NULL
kidney	NULL
fibroblast	NULL
cell	NULL
line	NULL
293T	NULL
.	NULL

Plasmid	NULL
effectors	NULL
coding	NULL
for	NULL
CIITA	NULL
(	NULL
pSVCIITA	NULL
)	NULL
and	NULL
CBP	NULL
(	NULL
pCMVCBP	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
plasmid	NULL
target	NULL
pDRASCAT	NULL
.	NULL

CAT	NULL
enzymatic	NULL
assays	NULL
were	NULL
performed	NULL
48	NULL
h	NULL
later	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
1	NULL
53	NULL
15	NULL
,	NULL
Fold-TA	NULL
150	NULL
Fas	NULL
[	NULL
4	NULL
100	NULL
9	NULL
«	NULL
C	NULL
p	NULL
&	NULL
|	NULL
``	NULL
°	NULL
U	NULL
0	NULL
CHTA	NULL
CBP	NULL
B	NULL
1	NULL
``	NULL
223	NULL
)	NULL
4	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

CHITA	NULL
and	NULL
CBP	NULL
act	NULL
synergistically	NULL
to	NULL
increase	NULL
expression	NULL
from	NULL
the	NULL
DRA	NULL
promoter	NULL
.	NULL

The	NULL
plasmid	NULL
target	NULL
(	NULL
pDRASCAT	NULL
)	NULL
was	NULL
coexpressed	NULL
with	NULL
CIITA	NULL
and/or	NULL
CBP	NULL
in	NULL
293T	NULL
cells	NULL
(	NULL
+	NULL
denotes	NULL
protein	NULL
expression	NULL
)	NULL
.	NULL

Amounts	NULL
of	NULL
cotransfected	NULL
plasmid	NULL
DNA	NULL
were	NULL
held	NULL
constant	NULL
(	NULL
0.25	NULL
pg	NULL
of	NULL
each	NULL
plasmid	NULL
effector	NULL
and	NULL
target	NULL
,	NULL
balanced	NULL
to	NULL
a	NULL
total	NULL
of	NULL
to	NULL
1.0	NULL
mg	NULL
with	NULL
the	NULL
empty	NULL
plasmid	NULL
vector	NULL
DNA	NULL
)	NULL
.	NULL

pDRASCAT	NULL
was	NULL
coexpressed	NULL
with	NULL
empty	NULL
plasmid	NULL
vector	NULL
(	NULL
white	NULL
bar	NULL
)	NULL
,	NULL
CIITA	NULL
(	NULL
gray	NULL
bar	NULL
)	NULL
,	NULL
CBP	NULL
(	NULL
striped	NULL
bar	NULL
)	NULL
,	NULL
or	NULL
CIITA	NULL
and	NULL
CBP	NULL
(	NULL
black	NULL
bar	NULL
)	NULL
.	NULL

Fold	NULL
transactivation	NULL
(	NULL
Fold-TA	NULL
)	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
bar	NULL
graph	NULL
and	NULL
represents	NULL
values	NULL
of	NULL
top	NULL
bars	NULL
over	NULL
the	NULL
value	NULL
obtained	NULL
with	NULL
pDRASCAT	NULL
alone	NULL
.	NULL

CAT	NULL
activities	NULL
represent	NULL
mean	NULL
values	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
with	NULL
indicated	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

RT-PCR	NULL
was	NULL
performed	NULL
on	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
293T	NULL
cells	NULL
transfected	NULL
as	NULL
noted	NULL
above	NULL
.	NULL

Primers	NULL
for	NULL
CIITA	NULL
mRNA	NULL
(	NULL
B	NULL
,	NULL
top	NULL
;	NULL
from	NULL
nucleotide	NULL
positions	NULL
3309	NULL
to	NULL
3507	NULL
)	NULL
or	NULL
human	NULL
TAP1	NULL
(	NULL
bottom	NULL
;	NULL
from	NULL
nucleotide	NULL
positions	NULL
1904	NULL
to	NULL
2247	NULL
)	NULL
were	NULL
used	NULL
in	NULL
the	NULL
PCR	NULL
.	NULL

CIITA	NULL
increased	NULL
the	NULL
expression	NULL
from	NULL
the	NULL
DRA	NULL
promoter	NULL
fivefold	NULL
over	NULL
baseline	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
column	NULL
2	NULL
)	NULL
.	NULL

CBP	NULL
had	NULL
a	NULL
smaller	NULL
effect	NULL
,	NULL
transactivating	NULL
the	NULL
DRA	NULL
promoter	NULL
only	NULL
threefold	NULL
(	NULL
column	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
coexpressed	NULL
,	NULL
CIITA	NULL
and	NULL
CBP	NULL
transactivated	NULL
the	NULL
DRA	NULL
promoter	NULL
15-fold	NULL
(	NULL
column	NULL
4	NULL
)	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
that	NULL
CBP	NULL
increased	NULL
the	NULL
transcription	NULL
of	NULL
CIITA	NULL
in	NULL
293T	NULL
cells	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
the	NULL
cotransfected	NULL
293T	NULL
cells	NULL
and	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
.	NULL

CIITA	NULL
mRNA	NULL
was	NULL
found	NULL
to	NULL
be	NULL
present	NULL
in	NULL
equal	NULL
amounts	NULL
when	NULL
plasmid	NULL
pSVCIITA	NULL
was	NULL
transfected	NULL
into	NULL
293T	NULL
cells	NULL
,	NULL
regardless	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
pCMVCBP	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
top	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
.	NULL

Control	NULL
RT-PCR	NULL
was	NULL
also	NULL
performed	NULL
with	NULL
primers	NULL
complementary	NULL
to	NULL
the	NULL
ubiquitously	NULL
expressed	NULL
human	NULL
TAP1	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

These	NULL
controls	NULL
indicated	NULL
that	NULL
CBP	NULL
did	NULL
not	NULL
affect	NULL
expression	NULL
from	NULL
the	NULL
DRA	NULL
promoter	NULL
due	NULL
to	NULL
increased	NULL
transcription	NULL
of	NULL
CIITA	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
both	NULL
CBP	NULL
and	NULL
CIITA	NULL
transactivate	NULL
the	NULL
DRA	NULL
promoter	NULL
and	NULL
do	NULL
so	NULL
in	NULL
a	NULL
synergistic	NULL
manner	NULL
.	NULL

CIITA	NULL
interacts	NULL
directly	NULL
with	NULL
CBP	NULL
in	NULL
cells	NULL
.	NULL

Since	NULL
functional	NULL
interactions	NULL
between	NULL
CIITA	NULL
and	NULL
CBP	NULL
could	NULL
reflect	NULL
physical	NULL
interactions	NULL
between	NULL
the	NULL
two	NULL
proteins	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
modified	NULL
one-hybrid	NULL
binding	NULL
assay	NULL
in	NULL
293T	NULL
cells	NULL
.	NULL

An	NULL
effector	NULL
plasmid	NULL
directing	NULL
expression	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
between	NULL
CIITA	NULL
and	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
yeast	NULL
Gal4	NULL
protein	NULL
(	NULL
pSGCIITA	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
a	NULL
single	NULL
Gal4	NULL
binding	NULL
site	NULL
(	NULL
UASg	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
pG1bCAT	NULL
)	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
hybrid	NULL
Gal4-CIITA	NULL
protein	NULL
increased	NULL
the	NULL
expression	NULL
from	NULL
pG1bCAT	NULL
threefold	NULL
over	NULL
baseline	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
column	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
inclusion	NULL
of	NULL
pCMVCBP	NULL
in	NULL
the	NULL
cotransfection	NULL
transactivated	NULL
pGIbCAT	NULL
18-fold	NULL
,	NULL
indicating	NULL
that	NULL
CBP	NULL
interacted	NULL
directly	NULL
with	NULL
CIITA	NULL
(	NULL
column	NULL
3	NULL
)	NULL
.	NULL

pCMVCBP	NULL
without	NULL
pSGCIITA	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
transcription	NULL
form	NULL
pG1bCAT	NULL
(	NULL
column	NULL
4	NULL
)	NULL
.	NULL

Direct	NULL
interactions	NULL
between	NULL
CIITA	NULL
and	NULL
CBP	NULL
could	NULL
also	NULL
be	NULL
demonstrated	NULL
in	NULL
COS	NULL
cells	NULL
,	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
A	NULL
1	NULL
3	NULL
1	NULL
18	NULL
,	NULL
Fold-TA	NULL
B	NULL
csr	NULL
[	NULL
F	NULL
]	NULL
F	NULL
30	NULL
Citra	NULL
|-IP	NULL
-	NULL
oHA	NULL
=-	NULL
CllTA	NULL
-	NULL
CBP	NULL
5	NULL
&	NULL
20	NULL
|	NULL
9	NULL
<	NULL
z	NULL
10	NULL
4	NULL
Input	NULL
O	NULL
HA	NULL
_	NULL
ewes	NULL
.	NULL

CIITA	NULL
+	NULL
-|-	NULL
|-	NULL
]	NULL
vector	NULL
1	NULL
2	NULL
-|-|-|-|-|-|	NULL
_	NULL
gal4CHITA	NULL
-	NULL
!	NULL

--	NULL
-|	NULL
--	NULL
|	NULL
CBP	NULL
1	NULL
2	NULL
3	NULL
4	NULL
CHTA	NULL
Ca	NULL
--	NULL
-	NULL
>	NULL
DNA	NULL
BD	NULL
[	NULL
7	NULL
|	NULL
UASg	NULL
|	NULL
T	NULL
|	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

CBP	NULL
interacts	NULL
with	NULL
CIITA	NULL
in	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
CBP	NULL
interacts	NULL
with	NULL
CIITA	NULL
in	NULL
a	NULL
modified	NULL
one-hybrid	NULL
assay	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
plasmid	NULL
target	NULL
(	NULL
pG1bCAT	NULL
)	NULL
was	NULL
coexpressed	NULL
with	NULL
Gal4-CIITA	NULL
and/or	NULL
CBP	NULL
in	NULL
293T	NULL
cells	NULL
(	NULL
+	NULL
denotes	NULL
protein	NULL
expression	NULL
)	NULL
.	NULL

Amounts	NULL
of	NULL
cotransfected	NULL
plasmid	NULL
DNA	NULL
were	NULL
held	NULL
constant	NULL
(	NULL
0.25	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
effector	NULL
and	NULL
target	NULL
,	NULL
balanced	NULL
to	NULL
a	NULL
total	NULL
of	NULL
to	NULL
1.0	NULL
ug	NULL
with	NULL
the	NULL
empty	NULL
plasmid	NULL
vector	NULL
DNA	NULL
)	NULL
.	NULL

pG1bCAT	NULL
was	NULL
coexpressed	NULL
with	NULL
empty	NULL
plasmid	NULL
vector	NULL
(	NULL
white	NULL
bar	NULL
)	NULL
,	NULL
Gal4-CIITA	NULL
(	NULL
grey	NULL
bar	NULL
)	NULL
,	NULL
CBP	NULL
(	NULL
striped	NULL
bar	NULL
)	NULL
,	NULL
or	NULL
Gal4-CIITA	NULL
and	NULL
CBP	NULL
(	NULL
black	NULL
bar	NULL
)	NULL
.	NULL

Fold	NULL
transactivation	NULL
(	NULL
Fold-TA	NULL
)	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
bar	NULL
graph	NULL
and	NULL
represents	NULL
values	NULL
of	NULL
top	NULL
bars	NULL
over	NULL
the	NULL
value	NULL
obtained	NULL
with	NULL
pG1bCAT	NULL
alone	NULL
.	NULL

CAT	NULL
activities	NULL
represent	NULL
mean	NULL
values	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
with	NULL
indicated	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

BD	NULL
,	NULL
binding	NULL
domain	NULL
;	NULL
T	NULL
,	NULL
TATA	NULL
box	NULL
.	NULL

(	NULL
B	NULL
)	NULL
CIITA	NULL
can	NULL
be	NULL
immunoprecipitated	NULL
with	NULL
CBP	NULL
in	NULL
cells	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pCMVCBP	NULL
(	NULL
1.0	NULL
mg	NULL
)	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
pCMVCBP	NULL
(	NULL
1.0	NULL
ug	NULL
)	NULL
and	NULL
pSVCIITA	NULL
(	NULL
1.0	NULL
ug	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
empty	NULL
plasmid	NULL
vector	NULL
was	NULL
included	NULL
to	NULL
maintain	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
transfected	NULL
plasmid	NULL
at	NULL
2.0	NULL
ug	NULL
.	NULL

One-quarter	NULL
of	NULL
the	NULL
cellular	NULL
lysate	NULL
used	NULL
for	NULL
the	NULL
immunoprecipitation	NULL
(	NULL
IP	NULL
)	NULL
was	NULL
examined	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
expressed	NULL
proteins	NULL
(	NULL
Input	NULL
)	NULL
.	NULL

Anti-CBP	NULL
(	NULL
«	NULL
CBP	NULL
)	NULL
immunoprecipitates	NULL
were	NULL
also	NULL
probed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
CIITA	NULL
by	NULL
Western	NULL
blotting	NULL
,	NULL
«	NULL
HA	NULL
,	NULL
anti-hemagglutinin	NULL
epitope	NULL
antibody	NULL
.	NULL

which	NULL
were	NULL
cotransfected	NULL
with	NULL
pCMVCBP	NULL
and	NULL
pSVCIITA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Cellular	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
anti-CPB	NULL
antibody	NULL
and	NULL
then	NULL
examined	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
CIHITA	NULL
in	NULL
these	NULL
immunoprecipitates	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Only	NULL
when	NULL
both	NULL
CBP	NULL
and	NULL
CIITA	NULL
were	NULL
coexpressed	NULL
was	NULL
CIITA	NULL
detected	NULL
in	NULL
our	NULL
CBP	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
CBP	NULL
increases	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
by	NULL
interacting	NULL
with	NULL
CHITA	NULL
.	NULL

CIITA	NULL
binds	NULL
to	NULL
a	NULL
specific	NULL
domain	NULL
of	NULL
CBP	NULL
in	NULL
vitro	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
produced	NULL
a	NULL
long	NULL
list	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
interact	NULL
directly	NULL
with	NULL
one	NULL
of	NULL
the	NULL
four	NULL
domains	NULL
of	NULL
CBP	NULL
(	NULL
22	NULL
)	NULL
.	NULL

These	NULL
sequences	NULL
contain	NULL
amino	NULL
acids	NULL
from	NULL
positions	NULL
1	NULL
to	NULL
101	NULL
,	NULL
461	NULL
to	NULL
661	NULL
,	NULL
1621	NULL
to	NULL
1891	NULL
,	NULL
and	NULL
2058	NULL
and	NULL
2163	NULL
in	NULL
CBP	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
CIITA	NULL
bound	NULL
specifically	NULL
to	NULL
CBP	NULL
,	NULL
we	NULL
created	NULL
fusion	NULL
proteins	NULL
between	NULL
these	NULL
four	NULL
domains	NULL
of	NULL
CBP	NULL
and	NULL
GST	NULL
.	NULL

These	NULL
chimeras	NULL
were	NULL
used	NULL
in	NULL
a	NULL
binding	NULL
assay	NULL
with	NULL
CIITA	NULL
,	NULL
which	NULL
was	NULL
transcribed	NULL
and	NULL
translated	NULL
with	NULL
onine	NULL
in	NULL
vitro	NULL
.	NULL

Hybrid	NULL
GST-CBP	NULL
proteins	NULL
,	NULL
along	NULL
with	NULL
any	NULL
bound	NULL
CIITA	NULL
,	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

One-tenth	NULL
of	NULL
the	NULL
CIHITA	NULL
protein	NULL
used	NULL
for	NULL
the	NULL
binding	NULL
reactions	NULL
is	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
1	NULL
.	NULL

When	NULL
CIITA	NULL
was	NULL
combined	NULL
with	NULL
glutathione-Sepharose	NULL
beads	NULL
,	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
complexed	NULL
with	NULL
GST	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
essentially	NULL
no	NULL
CIITA	NULL
bound	NULL
to	NULL
our	NULL
beads	NULL
.	NULL

Similarly	NULL
,	NULL
CIITA	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
GST-CBP	NULL
(	NULL
1-101	NULL
)	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
GST-CBP	NULL
(	NULL
461-661	NULL
)	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
or	NULL
GST-CBP	NULL
(	NULL
2058-2163	NULL
)	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
CIITA	NULL
bound	NULL
efficiently	NULL
to	NULL
GST-CBP	NULL
(	NULL
1621-1891	NULL
)	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

As	NULL
indicated	NULL
by	NULL
the	NULL
staining	NULL
ROLE	NULL
OF	NULL
CTB	NULL
IN	NULL
CLASS	NULL
II	NULL
GENE	NULL
TRANSCRIPTION	NULL
-	NULL
943	NULL
A	NULL
_	NULL
CBP	NULL
1099-1758	NULL
HAT	NULL
2058-2163	NULL
1-101	NULL
461-661	NULL
_	NULL
1107-1171	NULL
1621-1891	NULL
2442	NULL
&	NULL
L	NULL
__	NULL
``	NULL
]	NULL
Nuclear	NULL
CREB	NULL
Bromo	NULL
c-Fos	NULL
SRCI	NULL
hormone	NULL
c-Jun	NULL
domain	NULL
TFIIB	NULL
receptors	NULL
Myb	NULL
E1A	NULL
Sapl	NULL
RSKI	NULL
Taxl	NULL
p/iCAF	NULL
Myo-D	NULL
B	NULL
CHTA	NULL
1-101	NULL
461-661	NULL
GST	NULL
Beads	NULL
1621-1891	NULL
|	NULL
-CBP	NULL
GST	NULL
2058-2163	NULL
CHTA	NULL
Pull	NULL
Input	NULL
down	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
C	NULL
Input	NULL
;	NULL
-	NULL
GST	NULL
CBP	NULL
s	NULL
l	NULL
chimeras	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

CIITA	NULL
binds	NULL
to	NULL
CBP	NULL
via	NULL
residues	NULL
from	NULL
positions	NULL
1621	NULL
to	NULL
1891	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
CBP	NULL
.	NULL

Domains	NULL
which	NULL
interact	NULL
with	NULL
other	NULL
proteins	NULL
that	NULL
regulate	NULL
transcription	NULL
of	NULL
various	NULL
genes	NULL
are	NULL
depicted	NULL
as	NULL
gray	NULL
and	NULL
black	NULL
rectangles	NULL
(	NULL
22	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
vitro	NULL
binding	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
transcribed	NULL
and	NULL
translated	NULL
CIITA	NULL
and	NULL
GST-CBP	NULL
fusion	NULL
proteins	NULL
containing	NULL
amino	NULL
acids	NULL
from	NULL
positions	NULL
1	NULL
to	NULL
101	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
461	NULL
to	NULL
661	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
1621	NULL
to	NULL
1891	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
2058	NULL
to	NULL
2163	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

Glutathione-Sepharose	NULL
beads	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
GST	NULL
alone	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
CIITA	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
10	NULL
%	NULL
of	NULL
the	NULL
input	NULL
CIITA	NULL
protein	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Coomassie	NULL
blue-stained	NULL
SDS-polyacrylamide	NULL
gel	NULL
demonstrating	NULL
that	NULL
equivalent	NULL
amounts	NULL
of	NULL
GST-CBP	NULL
fusion	NULL
proteins	NULL
were	NULL
included	NULL
in	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

of	NULL
the	NULL
autoradiographed	NULL
gel	NULL
with	NULL
the	NULL
Coomassie	NULL
blue	NULL
dye	NULL
,	NULL
amounts	NULL
of	NULL
GST	NULL
and	NULL
GST-CBP	NULL
fusion	NULL
proteins	NULL
were	NULL
equivalent	NULL
in	NULL
these	NULL
binding	NULL
reactions	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
CIITA	NULL
binds	NULL
to	NULL
specific	NULL
sequences	NULL
of	NULL
CBP	NULL
which	NULL
are	NULL
found	NULL
in	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
the	NULL
HAT	NULL
domain	NULL
.	NULL

This	NULL
region	NULL
was	NULL
previously	NULL
demonstrated	NULL
to	NULL
bind	NULL
c-Fos	NULL
(	NULL
8	NULL
)	NULL
,	NULL
TFIIB	NULL
(	NULL
27	NULL
)	NULL
,	NULL
E1A	NULL
(	NULL
4	NULL
,	NULL
32	NULL
)	NULL
,	NULL
RSK1	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
MyoD	NULL
(	NULL
44	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
N-terminal	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
binds	NULL
to	NULL
CBP	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
determine	NULL
which	NULL
domain	NULL
of	NULL
CIITA	NULL
was	NULL
required	NULL
for	NULL
these	NULL
interactions	NULL
with	NULL
CBP	NULL
.	NULL

The	NULL
N-terminal	NULL
143	NULL
amino	NULL
acids	NULL
of	NULL
CIITA	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
an	NULL
independent	NULL
transcriptional	NULL
activation	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
(	NULL
43	NULL
,	NULL
55	NULL
)	NULL
.	NULL

This	NULL
region	NULL
is	NULL
rich	NULL
in	NULL
acidic	NULL
amino	NULL
acids	NULL
and	NULL
also	NULL
interacts	NULL
with	NULL
TAFp32	NULL
(	NULL
18	NULL
)	NULL
.	NULL

To	NULL
map	NULL
the	NULL
interaction	NULL
between	NULL
CBP	NULL
and	NULL
CIITA	NULL
,	NULL
two	NULL
partial	NULL
CIITA	NULL
proteins	NULL
,	NULL
one	NULL
spanning	NULL
the	NULL
activation	NULL
domain	NULL
from	NULL
positions	NULL
1	NULL
to	NULL
143	NULL
[	NULL
CIITA	NULL
(	NULL
1-143	NULL
)	NULL
]	NULL
and	NULL
the	NULL
other	NULL
containing	NULL
amino	NULL
acids	NULL
from	NULL
positions	NULL
144	NULL
to	NULL
1103	NULL
of	NULL
[	NULL
CHTA	NULL
(	NULL
143-1103	NULL
)	NULL
]	NULL
,	NULL
were	NULL
transcribed	NULL
and	NULL
translated	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

These	NULL
two	NULL
truncated	NULL
CIITA	NULL
proteins	NULL
were	NULL
allowed	NULL
to	NULL
interact	NULL
with	NULL
GST-CBP	NULL
(	NULL
1621-1891	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
demonstrated	NULL
,	NULL
the	NULL
full-length	NULL
CIITA	NULL
bound	NULL
to	NULL
GST-CBP	NULL
(	NULL
1621-1891	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
CHTA	NULL
(	NULL
143-1103	NULL
)	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
and	NULL
is	NULL
unable	NULL
to	NULL
transactivate	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
did	NULL
not	NULL
bind	NULL
significantly	NULL
to	NULL
GST-CBP	NULL
(	NULL
1621-1891	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
,	NULL
CIHITA	NULL
(	NULL
1-143	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
transcriptional	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
,	NULL
bound	NULL
to	NULL
GST-CBP	NULL
(	NULL
1621-1891	NULL
)	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

As	NULL
demon	NULL
944	NULL
FONTES	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
-	NULL
CIHTA	NULL
51-137	NULL
163-322	NULL
420-427	NULL
1130	NULL
C	NULL
T	NULL
]	NULL
Acidic	NULL
P/S/T	NULL
-	NULL
ATP/GTP	NULL
-|-|	NULL
-|-	NULL
|	NULL
GST-CBP	NULL
(	NULL
1621-1891	NULL
)	NULL
CHTA	NULL
CIHITA	NULL
(	NULL
L44-1130	NULL
)	NULL
CHTA	NULL
(	NULL
QL-143	NULL
)	NULL
Pull	NULL
down	NULL
1	NULL
2	NULL
3	NULL
C	NULL
came	NULL
|	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

CBP	NULL
binds	NULL
to	NULL
the	NULL
N-terminal	NULL
transcriptional	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
CIITA	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Structural	NULL
domains	NULL
:	NULL
Acidic	NULL
,	NULL
region	NULL
rich	NULL
in	NULL
acidic	NULL
amino	NULL
acids	NULL
;	NULL
P/S/T	NULL
,	NULL
region	NULL
rich	NULL
in	NULL
proline	NULL
,	NULL
serine	NULL
,	NULL
and	NULL
threonine	NULL
residues	NULL
;	NULL
ATP/GTP	NULL
,	NULL
putative	NULL
purine	NULL
ribonucleotide	NULL
binding	NULL
site	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
In	NULL
vitro	NULL
binding	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
transcribed	NULL
and	NULL
translated	NULL
full-length	NULL
CHTA	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
CIITA	NULL
(	NULL
144-1103	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
CHITA	NULL
(	NULL
1-143	NULL
)	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
GST-CBP	NULL
(	NULL
1621-1891	NULL
)	NULL
pull-down	NULL
assay	NULL
;	NULL
(	NULL
C	NULL
)	NULL
input	NULL
CIITA	NULL
and	NULL
truncated	NULL
CIITA	NULL
proteins	NULL
used	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

strated	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
equal	NULL
amounts	NULL
of	NULL
these	NULL
CIITA	NULL
proteins	NULL
were	NULL
included	NULL
in	NULL
our	NULL
binding	NULL
reactions	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
CBP	NULL
interacts	NULL
with	NULL
CIITA	NULL
via	NULL
its	NULL
N-terminal	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

DN-CBP	NULL
inhibits	NULL
the	NULL
transcriptional	NULL
synergy	NULL
between	NULL
CIITA	NULL
and	NULL
CBP	NULL
.	NULL

To	NULL
characterize	NULL
further	NULL
transcriptional	NULL
synergy	NULL
between	NULL
CIITA	NULL
and	NULL
CBP	NULL
,	NULL
we	NULL
created	NULL
a	NULL
dominant	NULL
negative	NULL
form	NULL
of	NULL
CBP	NULL
that	NULL
should	NULL
inhibit	NULL
the	NULL
function	NULL
of	NULL
the	NULL
wild-type	NULL
protein	NULL
.	NULL

Two	NULL
dominant	NULL
negative	NULL
forms	NULL
of	NULL
p300	NULL
,	NULL
a	NULL
factor	NULL
that	NULL
is	NULL
highly	NULL
related	NULL
to	NULL
CBP	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
6	NULL
)	NULL
.	NULL

We	NULL
transposed	NULL
the	NULL
amino	NULL
acid	NULL
coordinates	NULL
of	NULL
one	NULL
of	NULL
these	NULL
dominant	NULL
negative	NULL
p300	NULL
proteins	NULL
onto	NULL
the	NULL
sequence	NULL
of	NULL
CBP	NULL
to	NULL
create	NULL
DN-CBP	NULL
,	NULL
containing	NULL
amino	NULL
acids	NULL
from	NULL
positions	NULL
1903	NULL
to	NULL
2441	NULL
in	NULL
CBP	NULL
.	NULL

A	NULL
plasmid	NULL
effector	NULL
was	NULL
constructed	NULL
to	NULL
express	NULL
DN-CBP	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
(	NULL
pCRDN-CBP	NULL
)	NULL
.	NULL

pSVCIITA	NULL
and	NULL
pCMVCBP	NULL
were	NULL
cotransfected	NULL
with	NULL
pDRASCAT	NULL
into	NULL
293T	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
22-fold-increased	NULL
CAT	NULL
enzymatic	NULL
activity	NULL
over	NULL
baseline	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
column	NULL
3	NULL
)	NULL
.	NULL

Including	NULL
pCRDN-CBP	NULL
in	NULL
a	NULL
similar	NULL
cotransfection	NULL
transactivated	NULL
pDRASCAT	NULL
only	NULL
sixfold	NULL
(	NULL
column	NULL
4	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
DN-CBP	NULL
inhibited	NULL
the	NULL
function	NULL
of	NULL
its	NULL
wild-type	NULL
counterpart	NULL
.	NULL

DN-CBP	NULL
also	NULL
had	NULL
a	NULL
smaller	NULL
but	NULL
reproducible	NULL
effect	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
CIITA	NULL
to	NULL
activate	NULL
the	NULL
DRA	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenous	NULL
CBP	NULL
.	NULL

In	NULL
this	NULL
instance	NULL
,	NULL
the	NULL
cotransfection	NULL
of	NULL
pSVCIITA	NULL
and	NULL
pCRDN-CBP	NULL
transactivated	NULL
pDRASCAT	NULL
only	NULL
threefold	NULL
(	NULL
column	NULL
5	NULL
)	NULL
.	NULL

Cotransfecting	NULL
pCRDN-CBP	NULL
with	NULL
pDRASCAT	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
already	NULL
low	NULL
baseline	NULL
levels	NULL
of	NULL
expression	NULL
form	NULL
the	NULL
DRA	NULL
promoter	NULL
(	NULL
column	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
not	NULL
only	NULL
does	NULL
CBP	NULL
promote	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
but	NULL
DN-CBP	NULL
can	NULL
block	NULL
this	NULL
effect	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

10	NULL
50	NULL
220	NULL
60	NULL
30	NULL
Fold	NULL
TA	NULL
400	NULL
300	NULL
>	NULL
13	NULL
4	NULL
200	NULL
al	NULL
<	NULL
O	NULL
100	NULL
|	NULL
em	NULL
o	NULL
|	NULL
E	NULL
m	NULL
-l	NULL
4+	NULL
]	NULL
4+	NULL
]	NULL
4+	NULL
CHTA	NULL
<	NULL
-	NULL
]	NULL
<	NULL
+	NULL
CBP	NULL
-	NULL
<	NULL
+-|-	NULL
<	NULL
-|	NULL
<	NULL
+-|	NULL
pN-CBP	NULL
Io	NULL
2	NULL
30	NULL
4005006	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

DN-CBP	NULL
inhibits	NULL
the	NULL
transcriptional	NULL
synergy	NULL
between	NULL
CIITA	NULL
and	NULL
CBP	NULL
.	NULL

pDRASCAT	NULL
was	NULL
coexpressed	NULL
with	NULL
CIITA	NULL
individually	NULL
and	NULL
in	NULL
combination	NULL
with	NULL
CBP	NULL
in	NULL
293T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
DN-CBP	NULL
,	NULL
which	NULL
contains	NULL
amino	NULL
acids	NULL
from	NULL
positions	NULL
1903	NULL
to	NULL
2441	NULL
in	NULL
CBP	NULL
,	NULL
was	NULL
coexpressed	NULL
in	NULL
these	NULL
cells	NULL
Amounts	NULL
of	NULL
cotransfected	NULL
plasmids	NULL
were	NULL
kept	NULL
constant	NULL
(	NULL
0.5	NULL
ug	NULL
of	NULL
pDRASCAT	NULL
and	NULL
pCRDN-DBP	NULL
;	NULL
0.25	NULL
pg	NULL
of	NULL
pCMVCBP	NULL
and	NULL
pSVCIITA	NULL
;	NULL
empty	NULL
plasmid	NULL
vector	NULL
was	NULL
included	NULL
to	NULL
maintain	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
transfected	NULL
plasmid	NULL
at	NULL
2.0	NULL
pg	NULL
)	NULL
.	NULL

pDRASCAT	NULL
was	NULL
coexpressed	NULL
with	NULL
empty	NULL
plasmid	NULL
vector	NULL
(	NULL
white	NULL
bar	NULL
)	NULL
,	NULL
CIITA	NULL
(	NULL
gray	NULL
bar	NULL
)	NULL
,	NULL
CIITA	NULL
and	NULL
CBP	NULL
(	NULL
black	NULL
bar	NULL
)	NULL
,	NULL
CIITA	NULL
,	NULL
CBP	NULL
,	NULL
and	NULL
DN-CIITA	NULL
(	NULL
cross-hatched	NULL
bar	NULL
)	NULL
,	NULL
CIITA	NULL
and	NULL
DN-CBP	NULL
(	NULL
small-squares	NULL
bar	NULL
)	NULL
,	NULL
or	NULL
DN-CBP	NULL
(	NULL
striped	NULL
bar	NULL
)	NULL
.	NULL

Fold	NULL
transactivation	NULL
(	NULL
TA	NULL
)	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
bar	NULL
graph	NULL
and	NULL
represents	NULL
values	NULL
of	NULL
top	NULL
bars	NULL
over	NULL
the	NULL
value	NULL
obtained	NULL
with	NULL
pDRASCAT	NULL
alone	NULL
.	NULL

CAT	NULL
activities	NULL
represent	NULL
mean	NULL
values	NULL
of	NULL
three	NULL
different	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
with	NULL
indicated	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

DN-CBP	NULL
reduces	NULL
the	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
determinants	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
B-lymphoblastoid	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
CBP	NULL
played	NULL
a	NULL
similar	NULL
role	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
where	NULL
these	NULL
genes	NULL
and	NULL
CIITA	NULL
are	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
,	NULL
we	NULL
coexpressed	NULL
DN-CBP	NULL
and	NULL
CIITA	NULL
in	NULL
human	NULL
B-lymphoblastoid	NULL
RM3	NULL
cells	NULL
(	NULL
33	NULL
)	NULL
.	NULL

RM3	NULL
cells	NULL
are	NULL
mutant	NULL
Raji	NULL
cells	NULL
,	NULL
where	NULL
CIITA	NULL
is	NULL
no	NULL
longer	NULL
functional	NULL
.	NULL

However	NULL
,	NULL
the	NULL
introduction	NULL
of	NULL
CIITA	NULL
into	NULL
these	NULL
cells	NULL
leads	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
determinants	NULL
at	NULL
levels	NULL
observed	NULL
in	NULL
parental	NULL
Raji	NULL
cells	NULL
.	NULL

RM3	NULL
cells	NULL
were	NULL
chosen	NULL
because	NULL
they	NULL
synchronized	NULL
the	NULL
expression	NULL
of	NULL
DN-CBP	NULL
and	NULL
CIITA	NULL
proteins	NULL
and	NULL
avoided	NULL
the	NULL
issues	NULL
of	NULL
preexisting	NULL
high	NULL
levels	NULL
and	NULL
slow	NULL
turnover	NULL
of	NULL
class	NULL
II	NULL
determinants	NULL
in	NULL
wild-type	NULL
B-lymphoblastoid	NULL
cells	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
also	NULL
obtained	NULL
with	NULL
Raji	NULL
cells	NULL
,	NULL
which	NULL
expressed	NULL
DN-CBP	NULL
constitu-tively	NULL
(	NULL
data	NULL
not	NULL
presented	NULL
)	NULL
.	NULL

Forty-eight	NULL
hours	NULL
after	NULL
cotransfec-tion	NULL
,	NULL
RM3	NULL
cells	NULL
were	NULL
stained	NULL
for	NULL
class	NULL
II	NULL
and	NULL
class	NULL
I	NULL
determinants	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

As	NULL
the	NULL
green	NULL
fluorescence	NULL
protein	NULL
was	NULL
coexpressed	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
only	NULL
10	NULL
%	NULL
of	NULL
the	NULL
brightest	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
FACS	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
CIITA	NULL
alone	NULL
led	NULL
to	NULL
very	NULL
high	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
determinants	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
dark	NULL
gray	NULL
peak	NULL
)	NULL
.	NULL

At	NULL
a	NULL
ration	NULL
of	NULL
3	NULL
to	NULL
1	NULL
,	NULL
DN-CBP	NULL
protein	NULL
led	NULL
to	NULL
a	NULL
60	NULL
%	NULL
reduction	NULL
in	NULL
levels	NULL
of	NULL
class	NULL
II	NULL
determinants	NULL
(	NULL
HLA-DP	NULL
)	NULL
on	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
black	NULL
peak	NULL
)	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
,	NULL
no	NULL
reduction	NULL
in	NULL
levels	NULL
of	NULL
class	NULL
I	NULL
determinants	NULL
was	NULL
observed	NULL
with	NULL
DN-CBP	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
black	NULL
peak	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
CBP	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
in	NULL
B	NULL
cells	NULL
where	NULL
their	NULL
transcription	NULL
is	NULL
high	NULL
and	NULL
constitutive	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
CBP	NULL
can	NULL
reverse	NULL
the	NULL
inhibition	NULL
of	NULL
class	NULL
II	NULL
transcription	NULL
by	NULL
the	NULL
glucocorticoid	NULL
hormone	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
determine	NULL
if	NULL
CBP	NULL
had	NULL
a	NULL
role	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
class	NULL
II	NULL
transcription	NULL
by	NULL
the	NULL
glucocorticoid	NULL
hormone	NULL
.	NULL

Previous	NULL
studies	NULL
demonstrated	NULL
that	NULL
dexamethasone	NULL
(	NULL
9	NULL
,	NULL
47	NULL
)	NULL
and	NULL
ursodeoxycholic	NULL
acid	NULL
(	NULL
51	NULL
)	NULL
can	NULL
inhibit	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
and	NULL
that	NULL
this	NULL
inhibition	NULL
requires	NULL
the	NULL
translocation	NULL
of	NULL
GR	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Similarly	NULL
,	NULL
glucocorticoid	NULL
hor-	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
A	NULL
350	NULL
C	NULL
36	NULL
0	NULL
_	NULL
0	NULL
100	NULL
101	NULL
102	NULL
103	NULL
104	NULL
B	NULL
MHC	NULL
I	NULL
350	NULL
7	NULL
3	NULL
*	NULL
-I	NULL
0	NULL
-I	NULL
100	NULL
101	NULL
102	NULL
103	NULL
104	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

DN-CBP	NULL
inhibits	NULL
the	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
determinants	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
B-lymphoblastoid	NULL
RM3	NULL
cells	NULL
.	NULL

RM3	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
pSVCIITA	NULL
(	NULL
5	NULL
and	NULL
15	NULL
pg	NULL
of	NULL
empty	NULL
plasmid	NULL
vector	NULL
)	NULL
(	NULL
dark	NULL
gray	NULL
peaks	NULL
)	NULL
,	NULL
with	NULL
pSVCIITA	NULL
(	NULL
5	NULL
mg	NULL
)	NULL
and	NULL
pCRDN-CBP	NULL
(	NULL
15	NULL
pg	NULL
)	NULL
(	NULL
black	NULL
peaks	NULL
)	NULL
,	NULL
or	NULL
with	NULL
the	NULL
empty	NULL
plasmid	NULL
vector	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
(	NULL
light	NULL
gray	NULL
peaks	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
anti-HLA-DP	NULL
(	NULL
MHC	NULL
II	NULL
)	NULL
or	NULL
anti-HLA-A	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-C	NULL
(	NULL
MHC	NULL
I	NULL
)	NULL
antibodies	NULL
and	NULL
subsequently	NULL
visualized	NULL
with	NULL
a	NULL
phycocrythrin-conjugated	NULL
rat	NULL
anti-mouse	NULL
antibody	NULL
.	NULL

As	NULL
pEGFP	NULL
(	NULL
1	NULL
mg	NULL
)	NULL
was	NULL
cotransfected	NULL
into	NULL
these	NULL
cells	NULL
,	NULL
only	NULL
10	NULL
%	NULL
of	NULL
the	NULL
brightest	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
FACS	NULL
.	NULL

In	NULL
panel	NULL
A	NULL
,	NULL
two	NULL
light	NULL
gray	NULL
peaks	NULL
on	NULL
the	NULL
left	NULL
represent	NULL
unstained	NULL
and	NULL
anti-HLA-DP-stained	NULL
RM3	NULL
cells	NULL
that	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
plasmid	NULL
vector	NULL
alone	NULL
;	NULL
the	NULL
light	NULL
gray	NULL
peak	NULL
in	NULL
panel	NULL
B	NULL
represents	NULL
unstained	NULL
RM3	NULL
cells	NULL
.	NULL

mone	NULL
can	NULL
inhibit	NULL
the	NULL
ability	NULL
of	NULL
AP-1	NULL
to	NULL
activate	NULL
the	NULL
transcription	NULL
of	NULL
promoters	NULL
containing	NULL
an	NULL
AP-1	NULL
binding	NULL
site	NULL
(	NULL
23	NULL
,	NULL
31	NULL
,	NULL
46	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Kamei	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
demonstrated	NULL
that	NULL
one	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
inhibition	NULL
of	NULL
AP-1	NULL
might	NULL
occur	NULL
is	NULL
by	NULL
the	NULL
squelching	NULL
of	NULL
a	NULL
limited	NULL
amount	NULL
of	NULL
CBP	NULL
by	NULL
the	NULL
ligand-bound	NULL
GR	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Since	NULL
we	NULL
determined	NULL
that	NULL
CBP	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
test	NULL
if	NULL
a	NULL
similar	NULL
mechanism	NULL
of	NULL
squelching	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
class	NULL
II	NULL
transcription	NULL
by	NULL
the	NULL
glucocorticoid	NULL
hormone	NULL
.	NULL

pSVCIITA	NULL
was	NULL
transfected	NULL
into	NULL
293T	NULL
cells	NULL
,	NULL
which	NULL
transactivated	NULL
pDRASCAT	NULL
41-fold	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
column	NULL
2	NULL
)	NULL
.	NULL

When	NULL
these	NULL
cells	NULL
were	NULL
subsequently	NULL
treated	NULL
with	NULL
1	NULL
M	NULL
dexamethasone	NULL
,	NULL
transcriptional	NULL
activation	NULL
fell	NULL
sevenfold	NULL
to	NULL
sixfold	NULL
over	NULL
baseline	NULL
levels	NULL
,	NULL
even	NULL
though	NULL
identical	NULL
amounts	NULL
of	NULL
pSVCIITA	NULL
and	NULL
pDRASCAT	NULL
were	NULL
used	NULL
in	NULL
these	NULL
transfections	NULL
(	NULL
column	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
pCMVCBP	NULL
was	NULL
cotransfected	NULL
with	NULL
pSVCIHITA	NULL
and	NULL
pDRASCAT	NULL
,	NULL
this	NULL
inhibition	NULL
by	NULL
dexamethasone	NULL
was	NULL
reversed	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
(	NULL
columns	NULL
4	NULL
and	NULL
5	NULL
,	NULL
respec-tively	NULL
)	NULL
.	NULL

With	NULL
higher	NULL
amounts	NULL
of	NULL
pCMVCBP	NULL
,	NULL
levels	NULL
of	NULL
expression	NULL
increased	NULL
32-fold	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
dexamethasone	NULL
,	NULL
approaching	NULL
those	NULL
observed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
dexamethasone	NULL
(	NULL
compare	NULL
columns	NULL
2	NULL
and	NULL
5	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
this	NULL
glucocorticoid	NULL
hormone	NULL
inhibits	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
by	NULL
ROLE	NULL
OF	NULL
CTB	NULL
IN	NULL
CLASS	NULL
II	NULL
GENE	NULL
TRANSCRIPTION	NULL
-	NULL
945	NULL
1	NULL
41	NULL
8	NULL
20	NULL
32	NULL
Fold	NULL
TA	NULL
1000	NULL
800	NULL
600	NULL
400	NULL
200	NULL
0	NULL
CHTA	NULL
CBP	NULL
DEX	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
CBP	NULL
relieve	NULL
the	NULL
inhibition	NULL
of	NULL
class	NULL
II	NULL
transcription	NULL
by	NULL
dexamethasone	NULL
.	NULL

pDRASCAT	NULL
was	NULL
coexpressed	NULL
with	NULL
CIITA	NULL
,	NULL
and	NULL
transfected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
wM	NULL
dexamethasone	NULL
(	NULL
DEX	NULL
;	NULL
striped	NULL
bar	NULL
)	NULL
or	NULL
dimethyl	NULL
sulfoxide	NULL
vehicle	NULL
(	NULL
gray	NULL
bar	NULL
)	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
CBP	NULL
were	NULL
coexpressed	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
0.25	NULL
and	NULL
0.5	NULL
g	NULL
of	NULL
pCMVCBP	NULL
;	NULL
black	NULL
bars	NULL
)	NULL
.	NULL

Amounts	NULL
of	NULL
cotransfected	NULL
plasmids	NULL
were	NULL
kept	NULL
constant	NULL
(	NULL
0.5	NULL
g	NULL
of	NULL
pDRASCAT	NULL
and	NULL
0.75	NULL
of	NULL
pSVCIITA	NULL
;	NULL
0.25	NULL
pg	NULL
and	NULL
0.5	NULL
pg	NULL
of	NULL
pCMVCBP	NULL
;	NULL
empty	NULL
plasmid	NULL
vector	NULL
was	NULL
included	NULL
to	NULL
maintain	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
transfected	NULL
plasmid	NULL
at	NULL
2.0	NULL
pg	NULL
)	NULL
.	NULL

pDRASCAT	NULL
was	NULL
coexpressed	NULL
with	NULL
empty	NULL
plasmid	NULL
vector	NULL
(	NULL
white	NULL
bar	NULL
)	NULL
,	NULL
CIITA	NULL
(	NULL
gray	NULL
bar	NULL
)	NULL
,	NULL
CIITA	NULL
and	NULL
dexamethasone	NULL
(	NULL
striped	NULL
bar	NULL
)	NULL
,	NULL
or	NULL
CIITA	NULL
and	NULL
different	NULL
amounts	NULL
of	NULL
CBP	NULL
(	NULL
0.25	NULL
and	NULL
0.5	NULL
mg	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dexamethasone	NULL
(	NULL
black	NULL
bar	NULL
)	NULL
.	NULL

Fold	NULL
transactivation	NULL
(	NULL
TA	NULL
)	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
bar	NULL
graph	NULL
and	NULL
represents	NULL
values	NULL
of	NULL
top	NULL
bars	NULL
over	NULL
the	NULL
value	NULL
obtained	NULL
with	NULL
pDRASCAT	NULL
alone	NULL
.	NULL

CAT	NULL
activities	NULL
represent	NULL
mean	NULL
values	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
with	NULL
indicated	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

causing	NULL
the	NULL
GR	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
compete	NULL
with	NULL
CIITA	NULL
for	NULL
a	NULL
limited	NULL
amount	NULL
of	NULL
CBP	NULL
.	NULL

DISCUSSION	NULL
CIITA	NULL
is	NULL
the	NULL
key	NULL
regulatory	NULL
protein	NULL
for	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
48-50	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
identified	NULL
CBP	NULL
as	NULL
an	NULL
additional	NULL
coactivator	NULL
.	NULL

CBP	NULL
and	NULL
CIITA	NULL
not	NULL
only	NULL
synergized	NULL
in	NULL
the	NULL
transcription	NULL
from	NULL
the	NULL
DRA	NULL
promoter	NULL
but	NULL
physically	NULL
interacted	NULL
with	NULL
each	NULL
other	NULL
.	NULL

CIITA	NULL
bound	NULL
to	NULL
CBP	NULL
at	NULL
residues	NULL
from	NULL
positions	NULL
1621	NULL
to	NULL
1891	NULL
,	NULL
where	NULL
CBP	NULL
also	NULL
interacts	NULL
with	NULL
c-Fos	NULL
(	NULL
8	NULL
)	NULL
,	NULL
TFIIB	NULL
(	NULL
27	NULL
)	NULL
,	NULL
E1A	NULL
(	NULL
4	NULL
,	NULL
32	NULL
)	NULL
,	NULL
RSK1	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
MyoD	NULL
(	NULL
44	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
CBP	NULL
to	NULL
CIITA	NULL
occurred	NULL
via	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
.	NULL

DN-CBP	NULL
specifically	NULL
inhibited	NULL
the	NULL
transcriptional	NULL
synergy	NULL
between	NULL
CBP	NULL
and	NULL
CIITA	NULL
and	NULL
reduced	NULL
the	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
B-lymphoblastoid	NULL
cells	NULL
.	NULL

Our	NULL
study	NULL
also	NULL
provides	NULL
a	NULL
mechanistic	NULL
insight	NULL
into	NULL
the	NULL
inhibition	NULL
of	NULL
class	NULL
II	NULL
transcription	NULL
by	NULL
the	NULL
glucocorticoid	NULL
hormone	NULL
.	NULL

Not	NULL
only	NULL
did	NULL
dexamethasone	NULL
inhibit	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
,	NULL
but	NULL
the	NULL
overexpression	NULL
of	NULL
CBP	NULL
was	NULL
able	NULL
to	NULL
reverse	NULL
this	NULL
effect	NULL
.	NULL

It	NULL
was	NULL
reported	NULL
previously	NULL
that	NULL
the	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
dexamethasone	NULL
inhibited	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
9	NULL
,	NULL
47	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
required	NULL
the	NULL
translocation	NULL
of	NULL
GR	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
47	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
protein-DNA	NULL
binding	NULL
assays	NULL
suggested	NULL
that	NULL
GR	NULL
might	NULL
be	NULL
able	NULL
to	NULL
inhibit	NULL
the	NULL
binding	NULL
of	NULL
an	NULL
unidentified	NULL
complex	NULL
to	NULL
the	NULL
X1	NULL
box	NULL
of	NULL
the	NULL
DRB1	NULL
promoter	NULL
(	NULL
9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
using	NULL
an	NULL
in	NULL
vivo	NULL
binding	NULL
assay	NULL
(	NULL
16	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
dexamethasone	NULL
treatment	NULL
had	NULL
little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
effect	NULL
on	NULL
the	NULL
interaction	NULL
of	NULL
RFX	NULL
with	NULL
the	NULL
X	NULL
box	NULL
(	NULL
data	NULL
not	NULL
presented	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
Kamei	NULL
et	NULL
al	NULL
.	NULL

demonstrated	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
AP-1	NULL
by	NULL
dexamethasone	NULL
was	NULL
due	NULL
to	NULL
the	NULL
squelching	NULL
of	NULL
a	NULL
limited	NULL
amount	NULL
of	NULL
CBP	NULL
by	NULL
GR	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
the	NULL
overexpression	NULL
of	NULL
CBP	NULL
resulted	NULL
in	NULL
the	NULL
reversal	NULL
of	NULL
the	NULL
inhibition	NULL
by	NULL
dexamethasone	NULL
of	NULL
transcription	NULL
which	NULL
depended	NULL
on	NULL
a	NULL
tetradecanoyl	NULL
phorbol	NULL
ac-etate-responsive	NULL
element	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
by	NULL
STAT1	NULL
(	NULL
40	NULL
)	NULL
and	NULL
the	NULL
inhibition	NULL
of	NULL
AP-1	NULL
and	NULL
NF-kB	NULL
by	NULL
the	NULL
946	NULL
FONTES	NULL
ET	NULL
AL	NULL
.	NULL

cytoplasm	NULL
dexamethasone	NULL
@	NULL
fo	NULL
Ca	NULL
)	NULL
1_*	NULL
|	NULL
GRE	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Diagrammatic	NULL
representation	NULL
of	NULL
how	NULL
dexamethasone	NULL
inhibits	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
the	NULL
absence	NULL
of	NULL
dexamethasone	NULL
,	NULL
CBP	NULL
binds	NULL
to	NULL
CHITA	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
CIITA	NULL
is	NULL
attracted	NULL
to	NULL
class	NULL
II	NULL
promoters	NULL
via	NULL
RFX	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
X	NULL
box	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
administration	NULL
of	NULL
dexamethasone	NULL
results	NULL
in	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
GR	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
binds	NULL
to	NULL
CBP	NULL
.	NULL

In	NULL
this	NULL
manner	NULL
,	NULL
GR	NULL
sequesters	NULL
a	NULL
limited	NULL
amount	NULL
of	NULL
CBP	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
leaving	NULL
little	NULL
to	NULL
no	NULL
free	NULL
CBP	NULL
to	NULL
interact	NULL
with	NULL
CIITA	NULL
on	NULL
class	NULL
II	NULL
promoters	NULL
.	NULL

GRE	NULL
,	NULL
glucocortoid	NULL
response	NULL
element	NULL
.	NULL

androgen	NULL
receptor	NULL
are	NULL
also	NULL
due	NULL
to	NULL
the	NULL
competition	NULL
for	NULL
limiting	NULL
amounts	NULL
of	NULL
CBP	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
determined	NULL
that	NULL
the	NULL
decreased	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
following	NULL
the	NULL
administration	NULL
of	NULL
dexamethasone	NULL
could	NULL
be	NULL
reversed	NULL
by	NULL
the	NULL
overexpression	NULL
of	NULL
CBP	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
primary	NULL
mechanism	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
class	NULL
II	NULL
transcription	NULL
by	NULL
the	NULL
glucocorticoid	NULL
hormone	NULL
is	NULL
the	NULL
squelching	NULL
of	NULL
a	NULL
limited	NULL
amount	NULL
of	NULL
CBP	NULL
,	NULL
not	NULL
the	NULL
blocking	NULL
of	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
X	NULL
box	NULL
.	NULL

This	NULL
mechanism	NULL
is	NULL
presented	NULL
diagrammatically	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Direct	NULL
interactions	NULL
between	NULL
CIITA	NULL
and	NULL
CBP	NULL
were	NULL
mapped	NULL
to	NULL
the	NULL
N-terminal	NULL
transcriptional	NULL
activation	NULL
domain	NULL
of	NULL
CIITA	NULL
.	NULL

This	NULL
domain	NULL
is	NULL
rich	NULL
in	NULL
acidic	NULL
amino	NULL
acids	NULL
.	NULL

Mutageneses	NULL
of	NULL
this	NULL
region	NULL
identified	NULL
two	NULL
putative	NULL
«	NULL
helices	NULL
which	NULL
are	NULL
required	NULL
not	NULL
only	NULL
for	NULL
transcriptional	NULL
activation	NULL
but	NULL
also	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
CIITA	NULL
to	NULL
TAF	NULL
,	NULL
,32	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
CBP	NULL
with	NULL
CREB	NULL
occurs	NULL
via	NULL
the	NULL
so-called	NULL
KIX	NULL
domain	NULL
,	NULL
in	NULL
which	NULL
serine	NULL
133	NULL
of	NULL
CREB	NULL
is	NULL
phosphorylated	NULL
(	NULL
13	NULL
,	NULL
27	NULL
,	NULL
39	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
CREB	NULL
has	NULL
a	NULL
glutamine-rich	NULL
activation	NULL
domain	NULL
which	NULL
also	NULL
interacts	NULL
with	NULL
human	NULL
TAF	NULL
,	NULL
,130	NULL
(	NULL
37	NULL
)	NULL
.	NULL

It	NULL
appears	NULL
that	NULL
CIITA	NULL
may	NULL
also	NULL
function	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
,	NULL
not	NULL
only	NULL
contacting	NULL
a	NULL
component	NULL
of	NULL
TFIID	NULL
but	NULL
also	NULL
recruiting	NULL
CBP	NULL
and	NULL
its	NULL
associate	NULL
HAT	NULL
activity	NULL
.	NULL

Although	NULL
experiments	NULL
have	NULL
not	NULL
ruled	NULL
out	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
tripartite	NULL
complex	NULL
composed	NULL
of	NULL
TAF	NULL
;	NULL
,32	NULL
,	NULL
CBP	NULL
and	NULL
CIITA	NULL
,	NULL
it	NULL
seems	NULL
unlikely	NULL
that	NULL
this	NULL
would	NULL
occur	NULL
due	NULL
to	NULL
steric	NULL
consider-ations	NULL
.	NULL

Rather	NULL
,	NULL
CIITA	NULL
probably	NULL
interacts	NULL
with	NULL
these	NULL
two	NULL
complexes	NULL
at	NULL
different	NULL
times	NULL
in	NULL
the	NULL
transcription	NULL
cycle	NULL
.	NULL

CIITA	NULL
could	NULL
initiate	NULL
transcription	NULL
via	NULL
its	NULL
interactions	NULL
with	NULL
TFIID	NULL
and	NULL
subsequently	NULL
promote	NULL
chromatin	NULL
remodeling	NULL
by	NULL
recruiting	NULL
CBP	NULL
.	NULL

CBP	NULL
is	NULL
the	NULL
second	NULL
coactivator	NULL
which	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
binding	NULL
partner	NULL
for	NULL
CIHITA	NULL
,	NULL
which	NULL
is	NULL
itself	NULL
a	NULL
transcriptional	NULL
coactivator	NULL
.	NULL

The	NULL
B-cell-specific	NULL
coactivator	NULL
Bob-1	NULL
binds	NULL
to	NULL
CIITA	NULL
and	NULL
synergizes	NULL
with	NULL
it	NULL
in	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
transcription	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
depends	NULL
not	NULL
only	NULL
on	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
complex	NULL
protein-DNA	NULL
structure	NULL
but	NULL
also	NULL
on	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
multipartite	NULL
coactivator	NULL
network	NULL
.	NULL

CIITA	NULL
can	NULL
therefore	NULL
be	NULL
viewed	NULL
as	NULL
a	NULL
transcriptional	NULL
integrator	NULL
,	NULL
coordinating	NULL
the	NULL
communication	NULL
between	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
with	NULL
activities	NULL
that	NULL
promote	NULL
transcriptional	NULL
initiation	NULL
and	NULL
promoter	NULL
clearance	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Michael	NULL
Armanini	NULL
for	NULL
expert	NULL
secretarial	NULL
assistance	NULL
,	NULL
members	NULL
of	NULL
the	NULL
Peterlin	NULL
lab	NULL
and	NULL
Peter	NULL
Kushner	NULL
for	NULL
helpful	NULL
comments	NULL
and	NULL
discussions	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Rosenfeld	NULL
for	NULL
pCMVCBP	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
postdoctoral	NULL
fellowship	NULL
grant	NULL
from	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
to	NULL
J.D.F	NULL
.	NULL

and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Nora	NULL
Eccles	NULL
Treadwell	NULL
Foundation	NULL
to	NULL
B.M.P	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Aarnisalo	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
J.	NULL
Palvimo	NULL
,	NULL
and	NULL
O	NULL
.	NULL

A.	NULL
Janne	NULL
.	NULL

1998	NULL
.	NULL

CREB-binding	NULL
protein	NULL
in	NULL
androgen	NULL
receptor-mediated	NULL
signaling	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
:	NULL
2122-2127	NULL
.	NULL

2	NULL
.	NULL

Abdulkadir	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
S.	NULL
J	NULL
.	NULL

One	NULL
.	NULL

1995	NULL
.	NULL

How	NULL
are	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
turned	NULL
on	NULL
and	NULL
off	NULL
?	NULL

FASEB	NULL
J	NULL
.	NULL

9:1429-1435	NULL
.	NULL

3	NULL
.	NULL

Abraham	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
S.	NULL
Lobo	NULL
,	NULL
P.	NULL
Yaciuk	NULL
,	NULL
H.	NULL
G.	NULL
Wang	NULL
,	NULL
and	NULL
E.	NULL
Moran	NULL
.	NULL

1993.	NULL
p300	NULL
,	NULL
and	NULL
p300-associated	NULL
proteins	NULL
,	NULL
are	NULL
components	NULL
of	NULL
TATA-binding	NULL
protein	NULL
(	NULL
TBP	NULL
)	NULL
complexes	NULL
.	NULL

Oncogene	NULL
8:1639-1647	NULL
.	NULL

4	NULL
.	NULL

Arany	NULL
,	NULL
Z.	NULL
,	NULL
D.	NULL
Newsome	NULL
,	NULL
E.	NULL
Oldread	NULL
,	NULL
D.	NULL
M.	NULL
Livingston	NULL
,	NULL
and	NULL
R.	NULL
Eckner	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
family	NULL
of	NULL
transcriptional	NULL
adaptor	NULL
proteins	NULL
targeted	NULL
by	NULL
the	NULL
E1A	NULL
oncopro-tein	NULL
.	NULL

Nature	NULL
374:81-84	NULL
.	NULL

5	NULL
.	NULL

Arias	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
S.	NULL
Alberts	NULL
,	NULL
P.	NULL
Brindle	NULL
,	NULL
F.	NULL
X.	NULL
Claret	NULL
,	NULL
T.	NULL
Smeal	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
J.	NULL
Feramisco	NULL
,	NULL
and	NULL
M.	NULL
Montminy	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
cAMP	NULL
and	NULL
mitogen	NULL
responsive	NULL
genes	NULL
relies	NULL
on	NULL
a	NULL
common	NULL
nuclear	NULL
factor	NULL
.	NULL

Nature	NULL
370:226-229	NULL
.	NULL

6	NULL
.	NULL

Avantaggiati	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
V.	NULL
Ogryzko	NULL
,	NULL
K.	NULL
Gardner	NULL
,	NULL
A.	NULL
Giordano	NULL
,	NULL
A.	NULL
S.	NULL
Levine	NULL
,	NULL
and	NULL
K.	NULL
Kelly	NULL
.	NULL

1997	NULL
.	NULL

Recruitment	NULL
of	NULL
p300/CBP	NULL
in	NULL
pS3-dependent	NULL
signal	NULL
pathways	NULL
.	NULL

Cell	NULL
89:1175-1184	NULL
.	NULL

7	NULL
.	NULL

Bannister	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
Kouzarides	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
CBP	NULL
co-activator	NULL
is	NULL
a	NULL
histone	NULL
acctyltransferase	NULL
.	NULL

Nature	NULL
384:641-643	NULL
.	NULL

8	NULL
.	NULL

Bannister	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
Kouzarides	NULL
.	NULL

1995	NULL
.	NULL

CBP-induced	NULL
stimulation	NULL
of	NULL
c-Fos	NULL
activity	NULL
is	NULL
abrogated	NULL
by	NULL
E1A	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:4758-4762	NULL
.	NULL

9	NULL
.	NULL

Celada	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
McKercher	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Maki	NULL
.	NULL

1993	NULL
.	NULL

Repression	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
IA	NULL
expression	NULL
by	NULL
glucocorticoids	NULL
:	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
inhibits	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
X	NULL
box	NULL
DNA	NULL
binding	NULL
protein	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:691-698	NULL
.	NULL

10	NULL
.	NULL

Chang	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
J.	NULL
D.	NULL
Fontes	NULL
,	NULL
M.	NULL
Peterlin	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1994	NULL
.	NULL

Class	NULL
II	NULL
transactivator	NULL
(	NULL
CIITA	NULL
)	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1367-1374	NULL
.	NULL

11	NULL
.	NULL

Chen	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
J.	NULL
Lin	NULL
,	NULL
R.	NULL
L.	NULL
Schiltz	NULL
,	NULL
D.	NULL
Chakravarti	NULL
,	NULL
A.	NULL
Nash	NULL
,	NULL
L.	NULL
Nagy	NULL
,	NULL
M.	NULL
L.	NULL
Privalsky	NULL
,	NULL
Y.	NULL
Nakatani	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Evans	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
receptor	NULL
coactivator	NULL
ACTR	NULL
is	NULL
a	NULL
novel	NULL
histone	NULL
acetyltransferase	NULL
and	NULL
forms	NULL
a	NULL
multimeric	NULL
activation	NULL
complex	NULL
with	NULL
P/CAF	NULL
and	NULL
CBP/p300	NULL
.	NULL

Cell	NULL
90:569-580	NULL
.	NULL

12	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1987	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Bio-chem	NULL
.	NULL

162:156-159	NULL
.	NULL

13	NULL
.	NULL

Chrivia	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
R.	NULL
P.	NULL
Kwok	NULL
,	NULL
N.	NULL
Lamb	NULL
,	NULL
M.	NULL
Hagiwara	NULL
,	NULL
M.	NULL
R.	NULL
Montminy	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

1993	NULL
.	NULL

Phosphorylated	NULL
CREB	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
nuclear	NULL
protein	NULL
CBP	NULL
.	NULL

Nature	NULL
365:855-859	NULL
.	NULL

14	NULL
.	NULL

Dallas	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
P.	NULL
Yaciuk	NULL
,	NULL
and	NULL
E.	NULL
Moran	NULL
.	NULL

1997	NULL
.	NULL

Characterization	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
raised	NULL
against	NULL
p300	NULL
:	NULL
both	NULL
p300	NULL
and	NULL
CBP	NULL
are	NULL
present	NULL
in	NULL
intra-cellular	NULL
TBP	NULL
complexes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:1726-1731	NULL
.	NULL

15	NULL
.	NULL

Durand	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Kobr	NULL
,	NULL
W.	NULL
Reith	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
complementation	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
regulatory	NULL
mutants	NULL
by	NULL
the	NULL
purified	NULL
X-box-binding	NULL
protein	NULL
RFX	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6839-6847	NULL
.	NULL

16	NULL
.	NULL

Fontes	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
N.	NULL
Jabrane-Ferrat	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Peterlin	NULL
.	NULL

1997	NULL
.	NULL

Assembly	NULL
of	NULL
functional	NULL
regulatory	NULL
complexes	NULL
on	NULL
MHC	NULL
class	NULL
II	NULL
promoters	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

270:336-345	NULL
.	NULL

17	NULL
.	NULL

Fontes	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
N.	NULL
Jabrane-Ferrat	NULL
,	NULL
C.	NULL
R.	NULL
Toth	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Peterlin	NULL
.	NULL

1996	NULL
.	NULL

Binding	NULL
and	NULL
cooperative	NULL
interactions	NULL
between	NULL
two	NULL
B	NULL
cell-specific	NULL
transcriptional	NULL
coactivators	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:2517-2521	NULL
.	NULL

18	NULL
.	NULL

Fontes	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
B.	NULL
Jiang	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Peterlin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
class	NULL
II	NULL
transactivator	NULL
CIITA	NULL
interacts	NULL
with	NULL
the	NULL
TBP-associated	NULL
factor	NULL
TAFII32	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

25:2522-2528	NULL
.	NULL

19	NULL
.	NULL

Goldman	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
V.	NULL
K.	NULL
Tran	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
multifunctional	NULL
role	NULL
of	NULL
the	NULL
co-activator	NULL
CBP	NULL
in	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Recent	NULL
Prog	NULL
.	NULL

Horm	NULL
.	NULL

Res	NULL
.	NULL

52:103-119	NULL
.	NULL

20	NULL
.	NULL

Imhof	NULL
,	NULL
A.	NULL
,	NULL
X.	NULL
J.	NULL
Yang	NULL
,	NULL
V.	NULL
V.	NULL
Ogryzko	NULL
,	NULL
Y.	NULL
Nakatani	NULL
,	NULL
A.	NULL
P.	NULL
Wolffe	NULL
,	NULL
and	NULL
H.	NULL
Ge	NULL
.	NULL

1997	NULL
.	NULL

Acetylation	NULL
of	NULL
general	NULL
transcription	NULL
factors	NULL
by	NULL
histone	NULL
acetyltrans-ferases	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

7:689-692	NULL
.	NULL

21	NULL
.	NULL

Jabrane-Ferrat	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
D.	NULL
Fontes	NULL
,	NULL
J.	NULL
M.	NULL
Boss	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Peterlin	NULL
.	NULL

1996	NULL
.	NULL

Complex	NULL
architecture	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
promot-ers	NULL
:	NULL
reiterated	NULL
motifs	NULL
and	NULL
conserved	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:4683-4690	NULL
.	NULL

22	NULL
.	NULL

Janknecht	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
T.	NULL
Hunter	NULL
.	NULL

1996	NULL
.	NULL

Versatile	NULL
molecular	NULL
glue	NULL
.	NULL

Transcriptional	NULL
control	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

6951-954	NULL
.	NULL

23	NULL
.	NULL

Jonat	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
J.	NULL
Rahmsdorf	NULL
,	NULL
K.	NULL
K.	NULL
Park	NULL
,	NULL
A.	NULL
C.	NULL
Cato	NULL
,	NULL
S.	NULL
Gebel	NULL
,	NULL
H.	NULL
Ponta	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1990	NULL
.	NULL

Antitumor	NULL
promotion	NULL
and	NULL
antiinflammation	NULL
:	NULL
down-mod-ulation	NULL
of	NULL
AP-1	NULL
(	NULL
Fos/Jun	NULL
)	NULL
activity	NULL
by	NULL
glucocorticoid	NULL
hormone	NULL
.	NULL

Cell	NULL
62:1189-1204	NULL
.	NULL

24	NULL
.	NULL

Kamei	NULL
,	NULL
Y.	NULL
,	NULL
L.	NULL
Xu	NULL
,	NULL
T.	NULL
Heinzel	NULL
,	NULL
J.	NULL
Torchia	NULL
,	NULL
R.	NULL
Kurokawa	NULL
,	NULL
B	NULL
.	NULL

Gloss	NULL
,	NULL
S.	NULL
C.	NULL
Lin	NULL
,	NULL
R.	NULL
A.	NULL
Heyman	NULL
,	NULL
D.	NULL
W.	NULL
Rose	NULL
,	NULL
C.	NULL
K.	NULL
Glass	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
CBP	NULL
integrator	NULL
complex	NULL
mediates	NULL
transcriptional	NULL
activation	NULL
and	NULL
AP-1	NULL
inhibition	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40.	NULL
by	NULL
nuclear	NULL
receptors	NULL
.	NULL

Cell	NULL
85:403-414	NULL
.	NULL

Kara	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1991	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
:	NULL
bare	NULL
promoters	NULL
in	NULL
the	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
.	NULL

Science	NULL
252:709-712	NULL
.	NULL

Kee	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
J.	NULL
Arias	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Montminy	NULL
.	NULL

1996	NULL
.	NULL

Adaptor-mediated	NULL
recruitment	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
to	NULL
a	NULL
signal-dependent	NULL
activator	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:2373-2375	NULL
.	NULL

Kwok	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
J.	NULL
R.	NULL
Lundblad	NULL
,	NULL
J.	NULL
C.	NULL
Chrivia	NULL
,	NULL
J.	NULL
P.	NULL
Richards	NULL
,	NULL
H.	NULL
P.	NULL
Bachinger	NULL
,	NULL
R.	NULL
G.	NULL
Brennan	NULL
,	NULL
S.	NULL
G.	NULL
Roberts	NULL
,	NULL
M.	NULL
R.	NULL
Green	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

1994	NULL
.	NULL

Nuclear	NULL
protein	NULL
CBP	NULL
is	NULL
a	NULL
coactivator	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
CREB	NULL
.	NULL

Nature	NULL
.	NULL

370:223-226	NULL
.	NULL

Lin	NULL
,	NULL
Y.	NULL
S.	NULL
,	NULL
M.	NULL
F.	NULL
Carey	NULL
,	NULL
M.	NULL
Ptashne	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1988	NULL
.	NULL

GAL4	NULL
derivatives	NULL
function	NULL
alone	NULL
and	NULL
synergistically	NULL
with	NULL
mammalian	NULL
activators	NULL
in	NULL
vitro	NULL
.	NULL

Cell	NULL
54:659-664	NULL
.	NULL

Linhoff	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
K.	NULL
L.	NULL
Wright	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Ting	NULL
.	NULL

1997	NULL
.	NULL

CCAAT-binding	NULL
factor	NULL
NF-Y	NULL
and	NULL
RFX	NULL
are	NULL
required	NULL
for	NULL
in	NULL
vivo	NULL
assembly	NULL
of	NULL
a	NULL
nucleoprotein	NULL
complex	NULL
that	NULL
spans	NULL
250	NULL
base	NULL
pairs	NULL
:	NULL
the	NULL
invariant	NULL
chain	NULL
promoter	NULL
as	NULL
a	NULL
model	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:4589-4596	NULL
.	NULL

Louis-Plence	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
S.	NULL
Moreno	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Boss	NULL
.	NULL

1997	NULL
.	NULL

Formation	NULL
of	NULL
a	NULL
regulatory	NULL
factor	NULL
X/X2	NULL
box-binding	NULL
protein/nuclear	NULL
factor-¥	NULL
multiprotein	NULL
complex	NULL
on	NULL
the	NULL
conserved	NULL
regulatory	NULL
regions	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3899-3909	NULL
.	NULL

Lucibello	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
E.	NULL
P.	NULL
Slater	NULL
,	NULL
K.	NULL
U.	NULL
Jooss	NULL
,	NULL
M.	NULL
Beato	NULL
,	NULL
and	NULL
R.	NULL
Miiller	NULL
.	NULL

1990	NULL
.	NULL

Mutual	NULL
transrepression	NULL
of	NULL
Fos	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
:	NULL
involvement	NULL
of	NULL
a	NULL
functional	NULL
domain	NULL
in	NULL
Fos	NULL
which	NULL
is	NULL
absent	NULL
in	NULL
FosB	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:2827-2834	NULL
.	NULL

Lundblad	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
R.	NULL
P.	NULL
Kwok	NULL
,	NULL
M.	NULL
E.	NULL
Laurance	NULL
,	NULL
M.	NULL
L.	NULL
Harter	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Goodman	NULL
.	NULL

1995	NULL
.	NULL

Adenoviral	NULL
ElA-associated	NULL
protein	NULL
p300	NULL
as	NULL
a	NULL
functional	NULL
homologue	NULL
of	NULL
the	NULL
transcriptional	NULL
co-activator	NULL
CBP	NULL
.	NULL

Nature	NULL
374:85-88	NULL
.	NULL

Mach	NULL
,	NULL
B.	NULL
,	NULL
V.	NULL
Steimle	NULL
,	NULL
E.	NULL
Martinez-Soria	NULL
,	NULL
and	NULL
W.	NULL
Reith	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
genes	NULL
:	NULL
lessons	NULL
from	NULL
a	NULL
disease	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:301-331	NULL
.	NULL

Moreno	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
P.	NULL
Emery	NULL
,	NULL
J.	NULL
E.	NULL
West	NULL
,	NULL
B.	NULL
Durand	NULL
,	NULL
W.	NULL
Reith	NULL
,	NULL
B.	NULL
Mach	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Boss	NULL
.	NULL

1995	NULL
.	NULL

Purified	NULL
X2	NULL
binding	NULL
protein	NULL
(	NULL
X2BP	NULL
)	NULL
cooperatively	NULL
binds	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
X	NULL
box	NULL
region	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
purified	NULL
RFX	NULL
,	NULL
the	NULL
X	NULL
box	NULL
factor	NULL
deficient	NULL
in	NULL
the	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:4313-4321	NULL
.	NULL

Nakajima	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Fukamizu	NULL
,	NULL
J.	NULL
Takabashi	NULL
,	NULL
F.	NULL
H.	NULL
Gage	NULL
,	NULL
T.	NULL
Fisher	NULL
,	NULL
J.	NULL
Blenis	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Montminy	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
signal-dependent	NULL
coactivator	NULL
CBP	NULL
is	NULL
a	NULL
nuclear	NULL
target	NULL
for	NULL
pp9IORSK	NULL
.	NULL

Cell	NULL
86:465-474	NULL
.	NULL

Nakajima	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
Uchida	NULL
,	NULL
S.	NULL
F.	NULL
Anderson	NULL
,	NULL
C.	NULL
G.	NULL
Lee	NULL
,	NULL
J.	NULL
Hurwitz	NULL
,	NULL
J.	NULL
D.	NULL
Parvin	NULL
,	NULL
and	NULL
M.	NULL
Montminy	NULL
.	NULL

1997	NULL
.	NULL

RNA	NULL
helicase	NULL
A	NULL
mediates	NULL
association	NULL
of	NULL
CBP	NULL
with	NULL
RNA	NULL
polymerase	NULL
II	NULL
.	NULL

Cell	NULL
90:1107-1112	NULL
.	NULL

Nakajima	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
Uchida	NULL
,	NULL
S.	NULL
F.	NULL
Anderson	NULL
,	NULL
J.	NULL
D.	NULL
Parvin	NULL
,	NULL
and	NULL
M.	NULL
Montminy	NULL
.	NULL

1997	NULL
.	NULL

Analysis	NULL
of	NULL
a	NULL
cAMP-responsive	NULL
activator	NULL
reveals	NULL
a	NULL
two-component	NULL
mechanism	NULL
for	NULL
transcriptional	NULL
induction	NULL
via	NULL
signal-dependent	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:738-747	NULL
.	NULL

Ogryzko	NULL
,	NULL
V.	NULL
V.	NULL
,	NULL
R.	NULL
L.	NULL
Schiltz	NULL
,	NULL
V.	NULL
Russanova	NULL
,	NULL
B.	NULL
H.	NULL
Howard	NULL
,	NULL
and	NULL
Y.	NULL
Nakatani	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
transcriptional	NULL
coactivators	NULL
p300	NULL
and	NULL
CBP	NULL
are	NULL
histone	NULL
acetyltrans-ferases	NULL
.	NULL

Cell	NULL
87:953-959	NULL
.	NULL

Parker	NULL
,	NULL
D.	NULL
,	NULL
K.	NULL
Ferreri	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
V.	NULL
J.	NULL
LaMorte	NULL
,	NULL
R.	NULL
Evans	NULL
,	NULL
S.	NULL
C.	NULL
Koerber	NULL
,	NULL
C.	NULL
Hoeger	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Montminy	NULL
.	NULL

1996	NULL
.	NULL

Phosphorylation	NULL
of	NULL
CREB	NULL
at	NULL
Ser-133	NULL
induces	NULL
complex	NULL
formation	NULL
with	NULL
CREB-binding	NULL
protein	NULL
via	NULL
a	NULL
direct	NULL
mechanism	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:694-703	NULL
.	NULL

Parry	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
and	NULL
N.	NULL
Mackman	NULL
.	NULL

1997	NULL
.	NULL

Role	NULL
of	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
ROLE	NULL
OF	NULL
CTB	NULL
IN	NULL
CLASS	NULL
II	NULL
GENE	NULL
TRANSCRIPTION	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

947	NULL
binding	NULL
protein	NULL
in	NULL
cyclic	NULL
AMP	NULL
inhibition	NULL
of	NULL
NF-kappaB-mediated	NULL
transcrip-tion	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:5450-5456	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
M.	NULL
Kobr	NULL
,	NULL
P.	NULL
Emery	NULL
,	NULL
B.	NULL
Durand	NULL
,	NULL
C.	NULL
A.	NULL
Siegrist	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Cooperative	NULL
binding	NULL
between	NULL
factors	NULL
RFX	NULL
and	NULL
X2bp	NULL
to	NULL
the	NULL
X	NULL
and	NULL
X2	NULL
boxes	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
promoters	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:20020-20025	NULL
.	NULL

Reith	NULL
,	NULL
W.	NULL
,	NULL
C.	NULL
A.	NULL
Siegrist	NULL
,	NULL
B.	NULL
Durand	NULL
,	NULL
E.	NULL
Barras	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
promoters	NULL
requires	NULL
cooperative	NULL
binding	NULL
between	NULL
factors	NULL
RFX	NULL
and	NULL
NF-Y	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
:	NULL
554-558	NULL
.	NULL

Riley	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
S.	NULL
D.	NULL
Westerheide	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Price	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Brown	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Boss	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
requires	NULL
both	NULL
the	NULL
X	NULL
box	NULL
region	NULL
and	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CIITA	NULL
)	NULL
.	NULL

Immunity	NULL
2533-543	NULL
.	NULL

Sartorelli	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Huang	NULL
,	NULL
Y.	NULL
Hamamori	NULL
,	NULL
and	NULL
L.	NULL
Kedes	NULL
.	NULL

1997	NULL
.	NULL

Molecular	NULL
mechanisms	NULL
of	NULL
myogenic	NULL
coactivation	NULL
by	NULL
p300	NULL
:	NULL
direct	NULL
interaction	NULL
with	NULL
the	NULL
activation	NULL
domain	NULL
of	NULL
MyoD	NULL
and	NULL
with	NULL
the	NULL
MADS	NULL
box	NULL
of	NULL
MEF2ZC	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:1010-1026	NULL
.	NULL

Scholl	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
K.	NULL
Mahanta	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Strominger	NULL
.	NULL

1997	NULL
.	NULL

Specific	NULL
complex	NULL
formation	NULL
between	NULL
the	NULL
type	NULL
II	NULL
bare	NULL
lymphocyte	NULL
syndrome-associated	NULL
trans-activators	NULL
CIITA	NULL
and	NULL
RFX5	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:6330-6334	NULL
.	NULL

Schiile	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Rangarajan	NULL
,	NULL
S.	NULL
Kliewer	NULL
,	NULL
L.	NULL
J.	NULL
Ransone	NULL
,	NULL
J.	NULL
Bolado	NULL
,	NULL
N.	NULL
Yang	NULL
,	NULL
I.	NULL
M.	NULL
Verma	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Evans	NULL
.	NULL

1990	NULL
.	NULL

Functional	NULL
antagonism	NULL
between	NULL
onco-protein	NULL
c-Jun	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Cell	NULL
62:1217-1226	NULL
.	NULL

Schwiebert	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
R.	NULL
P.	NULL
Schleimer	NULL
,	NULL
S.	NULL
F.	NULL
Radka	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Ono	NULL
.	NULL

1995	NULL
.	NULL

Modulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
in	NULL
human	NULL
cells	NULL
by	NULL
dexamethasone	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

165:12-19	NULL
.	NULL

Silacci	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
Mottet	NULL
,	NULL
V.	NULL
Steimle	NULL
,	NULL
W.	NULL
Reith	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Developmental	NULL
extinction	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
in	NULL
plasmocytes	NULL
is	NULL
mediated	NULL
by	NULL
silencing	NULL
of	NULL
the	NULL
transactivator	NULL
gene	NULL
CIITA	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1329-1336	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
L.	NULL
A.	NULL
Otten	NULL
,	NULL
M.	NULL
Zufferey	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1993	NULL
.	NULL

Complementation	NULL
cloning	NULL
of	NULL
an	NULL
MHC	NULL
class	NULL
II	NULL
transactivator	NULL
mutated	NULL
in	NULL
hereditary	NULL
MHC	NULL
class	NULL
II	NULL
deficiency	NULL
(	NULL
or	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
)	NULL
.	NULL

Cell	NULL
75:135-146	NULL
.	NULL

Steimle	NULL
,	NULL
V.	NULL
,	NULL
C.	NULL
A.	NULL
Siegrist	NULL
,	NULL
A.	NULL
Mottet	NULL
,	NULL
B.	NULL
Lisowska-Grospierre	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
expression	NULL
by	NULL
interferon-gamma	NULL
mediated	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
CIITA	NULL
.	NULL

Science	NULL
265:106-109	NULL
.	NULL

Tanaka	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Makino	NULL
,	NULL
T.	NULL
Miura	NULL
,	NULL
F.	NULL
Hirano	NULL
,	NULL
K.	NULL
Okamoto	NULL
,	NULL
K.	NULL
Komura	NULL
,	NULL
Y.	NULL
Sato	NULL
,	NULL
and	NULL
I.	NULL
Makino	NULL
.	NULL

1996	NULL
.	NULL

Ligand-independent	NULL
activation	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
by	NULL
ursodeoxycholic	NULL
acid	NULL
.	NULL

Repression	NULL
of	NULL
IFN-gamma-induced	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
expression	NULL
via	NULL
a	NULL
glucocorticoid	NULL
receptor-dependent	NULL
path-way	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:1601-1608	NULL
.	NULL

Wright	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
B.	NULL
J.	NULL
Vilen	NULL
,	NULL
Y.	NULL
Itoh-Lindstrom	NULL
,	NULL
T.	NULL
L.	NULL
Moore	NULL
,	NULL
G.	NULL
Li	NULL
,	NULL
M.	NULL
Crisci-tiello	NULL
,	NULL
P.	NULL
Cogswell	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Clarke	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Ting	NULL
.	NULL

1994	NULL
.	NULL

CCAAT	NULL
box	NULL
binding	NULL
protein	NULL
NF-Y	NULL
facilitates	NULL
in	NULL
vivo	NULL
recruitment	NULL
of	NULL
upstream	NULL
DNA	NULL
binding	NULL
transcription	NULL
factors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4042-4053	NULL
.	NULL

Yang	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
V.	NULL
V.	NULL
Ogryzko	NULL
,	NULL
J.	NULL
Nishikawa	NULL
,	NULL
B.	NULL
H.	NULL
Howard	NULL
,	NULL
and	NULL
Y.	NULL
Nakatani	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
p300/CBP-associated	NULL
factor	NULL
that	NULL
competes	NULL
with	NULL
the	NULL
adenoviral	NULL
on-coprotein	NULL
ElA	NULL
.	NULL

Nature	NULL
382:319-324	NULL
.	NULL

Yang-Yen	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
J.	NULL
C.	NULL
Chambard	NULL
,	NULL
Y.	NULL
L.	NULL
Sun	NULL
,	NULL
T.	NULL
Smeal	NULL
,	NULL
T.	NULL
J.	NULL
Schmidt	NULL
,	NULL
J.	NULL
Drouin	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1990	NULL
.	NULL

Transcriptional	NULL
interference	NULL
between	NULL
c-Jun	NULL
and	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
:	NULL
mutual	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
due	NULL
to	NULL
direct	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Cell	NULL
62:1205-1215	NULL
.	NULL

Zhou	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
directed	NULL
by	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
CIITA	NULL
,	NULL
one	NULL
of	NULL
the	NULL
defective	NULL
genes	NULL
in	NULL
type	NULL
II	NULL
MHC	NULL
combined	NULL
immune	NULL
deficiency	NULL
.	NULL

Immunity	NULL
2545-553	NULL
.	NULL

